Next Article in Journal
Validation of the Glasgow Antipsychotic Side-Effect Scale (GASS) in an Italian Sample of Patients with Stable Schizophrenia and Bipolar Spectrum Disorders
Next Article in Special Issue
Feasibility of Canine Adenovirus Type 2 (CAV2) Based Vector for the Locus Coeruleus Optogenetic Activation in Non-Transgenic Rats: Implications for Functional Studies
Previous Article in Journal
Young Adult E-Cigarette and Combustible Tobacco Users Attitudes, Substance Use Behaviors, Mental Health, and Neurocognitive Performance
Previous Article in Special Issue
Delta Opioid Receptors and Enkephalinergic Signaling within Locus Coeruleus Promote Stress Resilience
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

The Neuromodulatory Role of the Noradrenergic and Cholinergic Systems and Their Interplay in Cognitive Functions: A Focused Review

1
Department of Biomedical Engineering, Columbia University, ET 351, 500 W. 120th Street, New York, NY 10027, USA
2
Vagelos College of Physicians and Surgeons, Columbia University, 630 West 168th Street, New York, NY 10032, USA
*
Author to whom correspondence should be addressed.
Brain Sci. 2022, 12(7), 890; https://doi.org/10.3390/brainsci12070890
Submission received: 2 June 2022 / Revised: 28 June 2022 / Accepted: 30 June 2022 / Published: 7 July 2022

Abstract

:
The noradrenergic and cholinergic modulation of functionally distinct regions of the brain has become one of the primary organizational principles behind understanding the contribution of each system to the diversity of neural computation in the central nervous system. Decades of work has shown that a diverse family of receptors, stratified across different brain regions, and circuit-specific afferent and efferent projections play a critical role in helping such widespread neuromodulatory systems obtain substantial heterogeneity in neural information processing. This review briefly discusses the anatomical layout of both the noradrenergic and cholinergic systems, as well as the types and distributions of relevant receptors for each system. Previous work characterizing the direct and indirect interaction between these two systems is discussed, especially in the context of higher order cognitive functions such as attention, learning, and the decision-making process. Though a substantial amount of work has been done to characterize the role of each neuromodulator, a cohesive understanding of the region-specific cooperation of these two systems is not yet fully realized. For the field to progress, new experiments will need to be conducted that capitalize on the modular subdivisions of the brain and systematically explore the role of norepinephrine and acetylcholine in each of these subunits and across the full range of receptors expressed in different cell types in these regions.

1. Introduction

The central nervous system performs an incredibly large number of continuous computations, the result of which is to efficiently process the external world and execute a relevant response. In the human brain, an estimated 1011 neurons make approximately 1000 average connections to other neurons, forming up to 1014 distinct sites for information transmission. That is likely an order of magnitude higher than the total number of cells in the entire human body [1]. Even this staggering number of physical connections understates the complexity of information handling in the brain. Beyond simple neuron-to-neuron connections, multiple subtypes of glial cells are also known to play a role in synaptic transmission [2,3]. This ever-shifting structural background, across which the flow of information proceeds throughout an individual’s life, is then capable of giving rise to a diverse array of orchestral melodies through the 100+ endogenous substances that play a role in modulating synaptic transmission [4]. Some of these substances, known as neurotransmitters, can act over varying physical distances through their interaction with a much larger number of receptors.
Since the discovery of the first neurotransmitter, acetylcholine, in 1926 by Otto Loewi, there has been an explosion in the identification and understanding of chemical neurotransmission. Conceptually simplified, information transfer occurs in two modes: electrical propagation within neurons or chemical propagation outside neurons. Neurotransmitters are the chemicals that traverse the physical division between cells connecting the postsynaptic cell with information from the presynaptic cell. This is primarily mediated through an array of specific receptors on the postsynaptic cell. For any given neuron, the combination of presynaptic inputs will determine if a message is electrically transcribed and transmitted. If it is transmitted, an action potential will travel down the length of a neuron, resulting in the release of extracellular neurotransmitter onto the dendrites of postsynaptic cells. The substances released are usually tightly regulated and reuptaken or degraded to limit the action of the substance on its target.
Generally, neurotransmitters may have excitatory, inhibitory, and neuromodulatory effects on neurons through the action of their receptors. Excitatory receptors, when activated by corresponding neurotransmitters, result in a membrane depolarization and the propagation of an action potential. Glutamate is the neurotransmitter that predominately mediates excitatory effects through its receptor, which is nearly ubiquitously expressed in all types of neurons and many types of glial cells [5]. Inhibitory receptors exert an opposing effect, with the binding of corresponding neurotransmitters resulting in a membrane hyperpolarization that limits the ability of a neuron to initiate an action potential. In the mature brain, γ-aminobutyric acid (GABA) is the primary neurotransmitter that exerts inhibitory effects on neurons through GABAergic receptors [6]. The interplay between these two competing systems has been studied in a variety of contexts [7,8,9] and provides the foundation for how neurotransmission is thought to occur in the brain. The summation of excitatory and inhibitory inputs at every connection point in the brain determines the direction and pattern of information propagation in complex networks of neurons. The third type of neurotransmitters, known as neuromodulators, add an additional, but important, complexity to this paradigm by altering the balance of transmission on a micro, meso, or macroscale.
There are four primary neuromodulatory systems: acetylcholine, norepinephrine, dopamine, and serotonin. Each of these four molecules plays an important function in altering basic synaptic transmission patterns. The groups of neurons responsible for the delivery of these four neuromodulators are known as ascending neuromodulatory systems since each of these neurotransmitters originates in the brainstem, midbrain, or basal forebrain and projects to various brain structures. While early work characterized these ascending modulatory systems as highly collateralized and largely exerting their influence through the global regulation of neural activity [10,11], more recent work has emphasized the subdivision of these systems into cortical-region-specific sub-systems that can differentially influence information processing [12,13]. Subsequently, there has been a shift away from viewing neuromodulatory systems as mere “state-setting” or “gating” systems toward a framework in which there is also an understanding that a subset of highly specific neuromodulatory projections to the forebrain, especially the cortex, are necessary for specific cognitive functions [14].
This review focuses on the role of two of these neuromodulatory systems, the noradrenergic and cholinergic systems, in modulating cognitive functions. Acetylcholine (ACh) is an important neuromodulator that has long been implicated in learning, memory, and synaptic plasticity [15,16]. More recent work, however, has also highlighted the role of ACh in attentional effort, orienting, and the detection of behaviorally significant stimuli [17,18]. Norepinephrine (NE) has classically been viewed as a major mediator of arousal that plays an important role in regulating the efficiency of external sensory processing [19,20,21,22,23,24,25]. Recent work expanding on this has revealed a varied and complex role for the noradrenergic system in everything from memory formation [26] to executive function and attention [27,28], to cognitive flexibility [29,30], and to decision-making [31,32,33]. Dysfunction in either of these two neuromodulatory systems or in the coordinated interaction between them is heavily implicated in numerous neurodegenerative and neuropsychiatric diseases [34,35,36,37,38,39,40,41].
Understanding the complex and dynamic role of neuromodulation on sophisticated behavioral outcomes requires not only an understanding of the full range of impact of each neuromodulator and its various anatomically distinct subdivisions but also an understanding of the interplay between multiple neuromodulatory systems. These interactions could occur at the functional level, seen in an organism’s behavior; the anatomic level, through connectomic communication; the cellular level, through intertwined signaling pathways; or even at the synaptic level, when important brain regions experience the release of multiple neurotransmitters. A more complete understanding of the role neuromodulation plays in brain functions will require a better understanding of when and how two systems, such as the cholinergic and noradrenergic systems, collectively work together. The implications will be critical for better understanding and predicting normal brain function and for providing novel treatment strategies for aberrant brain function.

2. Anatomical Overview

2.1. Cholinergic System

2.1.1. Sources

The cholinergic system is primarily comprised of groups of cells in the basal forebrain and midbrain that send diffuse but sparse projections to the rest of the brain [42,43,44,45,46,47,48,49,50,51,52]. Only the striatum differs with a local supply of cholinergic neurons for local transmission [53]. In primates, the cholinergic input to the cerebral cortex originates almost entirely from the nucleus basalis of Meynert (NBM), located in the basal forebrain [54]. These neurons are large with extensive dendritic trees, and a single neuron can innervate multiple brain regions, though there is minimal overlap in the axonal fields [50,55]. While cholinergic projections are widespread throughout the cortex, multiple studies have shown that there is a distinct pattern of segmented innervation depending on which nuclei in the basal forebrain the cholinergic neuron originates from [17,51,56,57,58].
A second major cholinergic source is found in the continuous array of multipolar neurons in the medial septum (MS) [46] and diagonal band of Broca (DB) [59,60]. A whole-brain atlas of projections from these regions in mice has found that cholinergic neurons were distributed in an uneven pattern between different brain regions, with neuronal density varying more than 10-fold across various structures [50]. Additionally, soma volume of cholinergic neurons varied by up to 8-fold across the examined regions [50]. Taken together, this work has demonstrated the existence of region-specific subtypes of cholinergic neurons that perform varying functions, though unlike in the nucleus basalis, there does not seem to be a specific relationship between soma location in the nuclei and the location of projections [50].

2.1.2. Inputs

Cholinergic neurons in the nucleus basalis (NB) receive dopaminergic input from the ventral tegmental area and substantial nigra, serotonergic input from the raphe nuclei, and noradrenergic input from the locus coeruleus [47,61]. The main cholinergic afferents to the nucleus basalis arrive from the midbrain pedunculopontine (PPT), the lateral dorsal tegmental (LDT) nuclei, and the limbic cortex [62,63,64]. There is also GABAergic input in the form of symmetric synapses, which could represent local inhibitory neurons or projections from other brain regions [65,66,67]. It has been shown in multiple studies that the cholinergic neurons originating in NB and projecting to the cortex are regulated through GABAergic receptors [47,61,65,66,67]. There is also extensive bidirectional communication between the nucleus basalis and the prefrontal cortex, and in mice, the rostral–caudal distribution of cholinergic cells in the basal forebrain is associated with projection to the superficial–deep layers of the ventral medial prefrontal cortex, respectively [49].
Both the PPT and LDT nuclei receive afferent projections from a widespread number of common structures, most predominately the reticular formation in the brainstem, the midbrain central gray region, and the lateral hypothalamus–zona incerta region [68,69]. Retrograde tracing studies have shown inputs arriving in the LDT nucleus from the midbrain reticular formation, the periaqueductal gray, the medial preoptic nucleus, the anterior hypothalamic nucleus, the perifornical and lateral hypothalamic areas, the premammillary nucleus, paraventricular hypothalamic nucleus, zona incerta, and the lateral habenular nucleus [46,70]. The PPT nucleus receives afferent inputs from a wide range of regions, reviewed in more depth by Martinez-Gonzalez in 2011 [71], but most notably including afferent connections from the cortex [69,72,73], various locations in the basal ganglia [69,74,75,76,77,78,79,80,81], the locus coeruleus [82], and the dorsal raphe [83].
The MS receives noradrenergic inputs from the locus coeruleus [45,84] and serotonergic inputs from the raphe nuclei [85], as well as additional inputs from several other brainstem nuclei [85]. Afferent projections to the DB have not been well characterized, partly due to its poorly defined margins. Some studies have shown afferent connections arriving from the supermammillary nucleus [86] and reciprocal connections with the CA2 subfield of the hippocampus [59].

2.1.3. Outputs

The nucleus basalis is an important source of ACh to the cerebral cortex [43,51,52,56,57], with efferent cholinergic projections that terminate on both pyramidal and GABAergic cells [55]. The nucleus basalis also supplies several thalamic nuclei with ACh, including the intralaminar nuclei, medial dorsal nucleus, and reticular nucleus [44,87]. Additional cells arise from the nucleus basalis that terminate throughout the amygdala, though most of these projections are GABAergic, with a minority being cholinergic [88,89].
The cholinergic nuclei in the midbrain, the PPT and LDT, have primary outputs that project to the nucleus accumbens, hypothalamus, raphe, and pontine and medullary reticular formations. They also project to the nucleus basalis, all thalamic nuclei, the amygdala, and the primary visual cortex [48,90]. The PPT, specifically, has long been thought to act as an interface between the basal ganglia and motor systems, though more recent work highlights the role of the varied neuronal subtypes and projections in updating behavioral states [91]. The LDT appears to play a significant role in activating the mesolimbic reward system [92].

2.2. Noradrenergic System

2.2.1. Sources

Noradrenergic projection to the forebrain is exclusively provided by a single source, the locus coeruleus (LC), which is a small, bilateral nucleus located in the pons [93,94,95,96,97]. A complete review of the LC was provided by Poe et al. in 2020 [98], but a brief description is provided here. Traditional investigations of the LC presumed it to be a broadly acting, primarily homogenous source of NE with wide implications [93,94,99,100], but more recent research has shown that the LC is composed of many distinct modules with highly specific functional roles throughout the brain [98]. There are two major, complementary theories on how a diffusely projecting single source of norepinephrine can achieve such disparate functional results. The first is that the function of NE release relies on regional differences in postsynaptic receptor distribution and resulting differences in spatiotemporal NE reuptake [101,102,103]. The second is a corollary to the function of the noradrenergic system in the periphery, in which the sympathetic nervous system has discrete efferent limbs that are organ specific but capable of acting in a unified manner [104,105]. In this theory, the LC provides localized neuromodulation to well-defined target regions and spiking is synchronized in highly specific subsets of LC neurons. For a more complete review, see Totah et al., 2019 [106].

2.2.2. Inputs

An important step in understanding the regional and modular functionality of the LC was achieved through an in-depth characterization of the afferent and efferent projections to and from the LC. The LC itself consists of a small, dense core, where cell bodies are found, and a peri-LC shell in which LC dendrites reside [107,108,109]. There are prominent afferent inputs to the LC core originating from the paragigantocellularis nucleus and the prepositus hypoglossi nuclei—both structures in the rostral medulla [110]. There are also additional inputs from the insular cortex, central nucleus of the amygdala, preoptic area, and the lateral and paraventricular hypothalamic areas [108,111,112]. Cerebellar Purkinje cells and neurons from deep cerebellar nuclei also provide synaptic inputs onto the core of the LC [108].
Although the projections of sensory afferents from the mesencephalic trigeminal sensory nucleus (Me5) [113,114] and the nucleus of tractus solitarius (NTS) [115] to the LC exert influences on cognitive functions [116], an important regulatory component on the core noradrenergic neurons in the LC include the peri-LC afferent innervations. Noradrenergic LC neurons possess long dendrites that pass through the surrounding small nuclei-like regions around the LC, which receive separate inputs from a variety of brain regions, including the prefrontal and infralimbic cortex, the amygdala, and the dorsal raphe nucleus [117]. There are additionally cholinergic, serotonergic, and adrenergic inputs to the peri-LC area, representing potential points of indirect regulation from other neuromodulatory systems [98,112]. The peri-LC zone also gives rise to several GABAergic inputs into the LC [118,119].

2.2.3. Outputs

The efferent projections from the LC are widespread but nonuniform to the neocortex in both rodents [102] and primates [120,121]. Collateral axons from the LC are distributed in a coordinated fashion to target circuits with a specific function [98,108,122,123,124,125,126]. The efferent projections from the LC travel throughout the brain, providing NE input to the cortex, insula, hippocampus, thalamus, amygdala, and cerebellum. A full review of this system was provided by Schwarz and Luo in 2015 [21]. Though the projections are widespread, the selective activation of specifically patterned noradrenergic neurons is poorly understood and likely involves a complex interplay between inputs into the LC and interacting systems [21]. Nevertheless, it has been shown that genetically distinct groups of noradrenergic neurons project to regionally and functionally specific circuits [127]. Understanding the anatomically distinct efferent circuits underlying specific functional consequences is an ongoing area of research that will likely improve our understanding of the role of the LC in the context of localized function.
As an important aspect of neuromodulation, the LC also directly projects to serotonergic, cholinergic, and dopaminergic nuclei, providing a centralized locus of control over, or feedback with, other neuromodulators [63,128].

2.3. Direct Communication between the Cholinergic and Noradrenergic Systems

Direct interactions between the cholinergic and noradrenergic systems are complex and likely highly dependent on regional context. Some example experiments have allowed an early understanding of some of these direct actions. Post-synaptic NE release inhibits approximately 90% of rat brainstem cholinergic neurons through the direct activation of inwardly rectifying K+ currents, most likely through the α2 adrenoreceptor [129]. In striatal cholinergic neurons, NE mediates depolarization through β1 adrenoreceptor activation [130]. It is also interesting to note that the LC has a unidirectional input into the basal forebrain, where a mix of α1 and β1 adrenoceptors are found on cholinergic neurons [131,132]. In the same region, however, GABAergic cells express α2, the activation of which suppresses neural activity. Overall, the net effect of LC modulation on the basal forebrain is the enhancement of ACh release in the cortex [21,133,134], though more sophisticated studies should be performed to determine the binding preference and net effect with varying levels of NE input [135].
Conversely, ACh acting on noradrenergic neurons is mediated primarily through α3 nicotinic receptors, leading to depolarization and NE release and the activation of the hypothalamic–pituitary–adrenal axis [136]. In the hippocampus, nicotinic receptors are also responsible for releasing NE from LC neuron terminals, likely through the NO/cGMP pathway [136,137]. Beyond evidence for local modulation of noradrenergic neurons by Ach [138,139], cholinergic receptors, presumed to be muscarinic, on LC neurons can act to centrally modulate LC firing. ACh induces increased firing rates, though the cholinergic source is not well understood.
These direct forms of interactive modulation demonstrate that even in the simplest scenarios in which cholinergic or noradrenergic activity occurs, the other system is being engaged. Whether or not this results in a synergistic or antagonistic effect likely depends on the extent to which each system is activated, the distribution of receptors in targeted regions, and the relative concentrations of each.

2.4. Indirect Communication of Cholinergic and Noradrenergic Systems

Cholinergic and noradrenergic projections to the prefrontal cortex are important for a variety of cognitive and executive functions. As such, neuromodulatory connections to distinct areas in the cortex such as the anterior cingulate cortex (ACC), medial prefrontal cortex (mPFC), and orbitofrontal cortex (OFC) control important aspects of an animal’s behavior [140,141,142,143]. An important study by Chandler et al. in 2014 showed that while both cholinergic and noradrenergic neurons projected to the cortex from their respective nuclei, their pattern of distribution varied across subregions in the prefrontal cortex [144]. Cholinergic neurons appeared to occur throughout all regions in a relatively equal distribution, while noradrenergic neurons projected to much more defined locations, which did not overlap with other monoaminergic projections [144].
Much of what is currently known about cholinergic and noradrenergic interaction has been researched in the context of various functional outcomes or neurological disease models. In a sheep model of chronic pain, concentrations of ACh and NE in the cerebral spinal fluid were measured and found to only be correlated to one another in those animals with pain [145]. In Alzheimer’s disease (AD), the close interplay between ACh and NE is being increasingly investigated under a theory that AD is a broad neuromodulatory disorder as opposed to a dysfunction of primarily the cholinergic system [34,146]. Locomotor activity, a process often disrupted in a wide array of neurological disorders, has also been shown to be mediated through cholinergic interaction with the noradrenergic system [147]. In attentional disorders, there is evidence indicating deficits in norepinephrine-mediated control of the cholinergic system in the parietal cortex [148].
An extremely important, though substantially under-researched, mode by which indirect interactions between these neuromodulatory systems occur is in their differential effect in glial cells such as astrocytes. Specifically, it has been shown that each neuromodulator has a specific effect on astrocyte potassium clearance, thereby regulating the extracellular potassium concentration and influencing local synaptic transmission [149].
There are also examples in the literature of the indirect engagement of the noradrenergic system that is likely mediated by α7 nicotinic receptors on GABAergic neurons and a resulting disinhibitory effect [150]. Supporting this is the direct measurement of increased ACh and NE in the rat cortex after administration of a nicotinic agonist [151]. It is important to note here that a simple increase and decrease in neurotransmitter level is not enough to discern the role of that change in a functional capacity. A more thorough understanding of the location, receptors, and other systems involved is needed to unravel functional consequences.

3. Role of Acetylcholine in the Brain

3.1. Major Cholinergic Receptor Subtypes and Function

The cholinergic system exerts its action by binding to two distinct receptor classes: nicotinic and muscarinic. Nicotinic acetylcholine receptors (nAChRs) are composed of five subunits arranged around a central core, forming a transmembrane channel that conducts Na+, K+, and Ca2+ when bound to ACh, leading to a local membrane depolarization [152]. The assembled receptor is constructed using two primary families of α and β subunits [152]. The standard neuronal configuration includes combinations of α2 through α6 and β2 through β4 proteins [153,154]. There are additional homomeric configurations composed of α7 through α9 subunits [155]. The central nervous system appears to be predominately composed of α4β2 or α7 nAChRs, of which the former has a higher affinity for ACh [156]. In the adult rat brain, there is little anatomical overlap between the heteromeric and homomeric nAChR types, indicating two distinct modes of ACh activity within distinct anatomical regions [157]. Overall, nAChRs are distributed widely but sparsely throughout the hippocampus and cortex at both pre- and postsynaptic locations [152] and expressed on interneurons, pyramidal cells, and stellate cells [158,159,160,161]. A series of previous experiments have shown that layers I, III, and V in the human cortex exhibit the highest binding of ACh. This was slightly different in the primary somatosensory cortex, where binding in layer III was highest, and in the primary motor cortex, where layers III and V were the highest [162]. The α7 receptors are expressed broadly across almost all glutaminergic and GABAergic neurons, though regional differences have been noted. The presence of a presynaptic nAChR almost universally results in an increased neurotransmitter release, across multiple types of neurotransmitters [152,163].
Muscarinic receptors (MAChR) are expressed throughout all layers of the cortex, though layers II and V exhibit the highest concentration [164]. There is a total of five known muscarinic receptor subtypes: M1 to M5. In general, M1 receptors are most abundant in the neocortex, hippocampus, and striatum [165]; M2 receptors are located throughout the entire brain [166]; M3 receptors only have a low level of expression throughout the brain [164]; M4 receptors are localized in the striatum [167]; and M5 receptors are also widely distributed across the brain [118]. These receptors have a seven-transmembrane region that is highly conserved in G-protein coupled receptors (GPCRs) and activates multiple intracellular signaling pathways, including phospholipase C (by M1, M3, M5), the inhibition of adenylyl cyclase (by M2 and M4), and the regulation of several ion channels [168,169]. MAChRs also activate mitogen-activated protein kinases (MAPKs), which regulates cell survival, differentiation, and synaptic plasticity [170,171,172].

3.2. Cholinergic Involvement in Learning and Decision Making

The cholinergic system plays an important role in higher cognitive functions, specifically in decision making and the learning process. Neuromodulation by acetylcholine is generally orchestrated through the differential activation of the nicotinic and muscarinic receptors. The nicotinic receptor, for example, has been shown to be easily desensitized and upregulated through the presence of nicotine, inducing long-term alterations in the decision-making process [173]. Nicotine has also been implicated in increasing impulsivity and disinhibition in decision-making [174]. Studies have also shown how nAChRs seem to be important in adapting appropriate choices to a specific outcome [175]. Specifically, the nAChR α7 receptor has been implicated in slowing learning rates in mice during knockout experiments [4], as well as cognitive improvement during enhanced activation [176].
Both nAChRs and MAChRs have been identified to contribute to risk and uncertainty [177], with several studies showing that a complex interaction between these two receptors contributes to cholinergic interneuron patterned activity [178,179]. This interaction seems to have a larger implication for network dynamics across different brain regions. Specifically, studies where MAChRs or nAChRs were activated or blocked demonstrated changes in neural synchrony across multiple EEG bands, invoking the emergence of theta-gamma coupling in the cortex and exhibiting a correlation to increased learning performance in item–context association behaviors [180,181].
Acetylcholine on a global level in the brain has been found to be relevant in almost every decision-making paradigm. Lesioning studies of the basal forebrain have shown disruptions in reversal learning in marmosets [182], as well as being implicated in memory storage [183,184]. The role of ACh in memory has been shown to act as a modulator of update speed and as a controller of meta learning [185]. Here, ACh modulates different neural systems throughout learning, regulating the appropriate amount of ACh in specific brain regions to appropriately and effectively learn and formulate memories [186].

3.3. Cholinergic Involvement in Attention

Cholinergic release primarily mediates attentional processing in the brain [17,187]. In a five-choice serial reaction time task (5-CSRTT), the nicotinic facilitation of attention was found to exist, and the magnitude of this facilitation was dependent on the level of attentional engagement [188]. In addition, by using the 5-CSRT, Robbins and colleagues demonstrated that nicotinic β2 subunits in the prelimbic cortex are crucial for mice to successfully detect a cue [189]. In an operant sustained attention task (SAT), both the detection of signals and the attentional performance were enhanced by the α4β2 nAChR agonist-evoked ACh increases in the mPFC [190]. In a knockout study, it was shown that task performance, which relies on highly attentive control, was impaired in a group of mice lacking the β2 subunit in the mPFC, in comparison with their wild-type littermates [191]. Similarly, the genetic deletion of this special subtype of nAChRs also results in compromised performance in an auditory discrimination paradigm [190], suggesting its critical role in selective auditory attention.
In addition, there is evidence implying that the muscarinic system plays a role in directing attentional selection mechanisms [192,193,194]. Specifically, muscarinic receptors are believed to primarily modulate higher-level visual stimulus processing [194]. Attending to the receptive field of certain V1 neurons evokes an increase in these neurons’ firing rates, and scopolamine, a muscarinic antagonist, reduces this attentional modulation [195]. Interestingly, nicotinic antagonist does not exert a systematic effect [195]. Yet another aspect which can also be associated with attentional control is adaptive behavioral control [196]. Various genotypes of M2 modulate the high-level inhibitory control processes that require the processing of prior information and suppression of irrelevant information [196].

4. Role of Norepinephrine in the Brain

4.1. Major Noradrenergic Receptor Subtypes

The noradrenergic system exerts influence over brain function through three receptor classes: α1, α2, and β receptors. Each of these receptors has control over specific processes of neurotransmission and sympathetic nervous system regulation. α1 receptors are members of the adrenoreceptor family, a subset of G-protein coupled receptors [197]. They have been further classified into three distinct subtypes: α1A, α1B, and α1D. Each subreceptor has demonstrated unique quantitative differences in effect [197]. Several experiments have explored the different concentrations of these subtypes throughout the brain. Specifically, it has been shown that α1B was more prominent in the thalamus, lateral amygdaloid nuclei, and cortical laminar areas, while α1A was higher in the entorhinal cortex, amygdala, and general cerebral cortex areas [198]. Furthermore, transgenic mouse experiments have allowed for specific receptors to be knocked out, uncovering that both α1A and α1B have a similar expression throughout the central nervous system, just with different abundances [199]. Around 55% of the brain was shown to express α1A, 35% α1B, and less than 10% was found to express α1D [200,201,202]. The function of α1 receptors is implicated in a variety of cognitive processes and synaptic efficacies. Beginning with synaptic involvement, α1 receptors have been shown to increase the firing frequency of pyramidal and somatosensory neurons of the visual cortex through the protein kinase C signaling (PKC) pathway [203,204]. They have also been implicated in the enhancement of glutamate and acetylcholine release as well as neuronal excitation via PKC pathways, calcium pathways, and excitatory synapses [205,206,207,208,209]. α1 has also been shown to affect non-neuronal function as well, with the modulation of synaptic transmission through astrocytes and glial cells [210,211,212]. With regards to cognitive functions, α1 receptors have been shown to be implicated in memory, motor and motivational behavior, memory retention, and storage, but most of these are associated with general norepinephrine release in the brain [213].
α2 receptors are also a type of G-protein coupled adrenoreceptor, classified into three subtypes: α2A, α2B, and α2C. Specifically, α2 receptors have been implicated in orchestrating the presynaptic inhibition of norepinephrine in the central and peripheral nervous system [214,215,216]. This inhibition is critical for regulation of normal involuntary processes including physiological functions of the heart, vision, and gastrointestinal systems. Using pharmacological agents such as prazosin or oxymetazoline, α2A and α2B receptors have been shown to have significant control over sympathetic outflow and blood pressure [216]. Several other studies have shown α2A receptor agonists enhance both serotonin and norepinephrine release [216]. Interestingly, the abundance of α2 receptor subtypes is much more localized than α1. While literature here is limited, studies have shown that α2B receptors are found almost exclusively in the thalamus, while α2C receptors are found in the olfactory bulb, cerebral cortex, hippocampal formation, and dorsal root ganglia [217].
The final type of noradrenergic receptors, classified as β, are also a G-protein coupled receptor, divided into three subtypes: β1, β2, β3 [216]. There have been studies linking β receptors to synaptic plasticity, with norepinephrine acting on β receptors to dictate synaptic strength in hippocampal neurons, as well as NE released from the locus coeruleus enhancing LTD-related memory processing [218].

4.2. Noradrenergic Involvement in Learning and Decision Making

The noradrenergic system has been implicated in a variety of decision-making paradigms as well as throughout the learning process. Studies using optogenetics, pharmacological agents, and lesioning have brought to light the effect norepinephrine has on cognition and higher-order thought processes. One theory regarding the role of NE in decision making involves the idea of network reset, acting as an “internal interrupt” signal [219,220]. Here, it is explained that the phasic activation of locus coeruleus noradrenergic neurons causes an increase of NE throughout the cortex, invoking cognitive shifts and the potential reorganization of neural networks [221]. This shifted brain state is hypothesized to be better equipped for rapid behavioral adaptation and enhanced decision making [221]. Other theories point out how stimulus-induced firing patterns of the LC are closely attuned to behavioral performance, hypothesized from LC primate recordings in visual discrimination tasks [28]. Similar phasic activation in primates has shown how the LC can respond to specific task-related decisions, modulating NE release and adapting future task-relevant decisions [186], as well as showcasing coordinated activity patterns in cortical networks derived from ascending NE projections [222]. Studies invoking NE release through an agonist have shown enhancements in sensory stimulation, allowing more rapid synaptic plasticity and faster behavioral responses [223].
Several pharmacological experiments have investigated the specific role that α2 receptors play in the decision-making process. Studies using NE antagonists have shown α2A receptor knockout leading to more risk-on behavior, with rats exhibiting greedier decisions [224]. α2A agonists have been proven to enhance the efficiency of working memory and reduce impulsivity in primates [225]. This increased receptor uptake in the prefrontal cortex seems to be part of the shifted network brain state described earlier. The agonist guanfacine, another α2A agent, was also shown to improve visual object discrimination performance during a reversal learning paradigm in primates [226].

4.3. Noradrenergic Involvement in Attention

The noradrenergic modulation of attention has been studied for several decades [227,228,229]. Studies have established the theory that the LC-NE system regulates the efficacy of information processing during neural coding of sensory signals [20,230,231]. During behavioral tasks, selective attention enhances neuronal responsiveness to sensory cues [232,233]. The firing rates of LC neurons are correlated with attentive behavior in an odd-ball task [227], in which either high or low tonic firing rates correspond to inattentive states and medium firing rates are associated with animals’ best performance. In a novel environment where more adaptive behaviors are required, changes in electrotonic coupling among LC neurons regulate goal-directed exploration and preserve attentional selectivity [28]. In addition, some studies have investigated the effects of NE agonists. It is shown that in a cued target detection task (CTD), the application of α2 receptor agonists clonidine or guanfacine significantly impaired alerting behavior, and the effect was dose-dependent [234], while the effect was blocked by the α2 antagonists idazoxan or yohimbine.
Most recent studies also show an association between the NE system and impulsivity control [235,236,237]. It was observed from the superior frontal theta band activity that the NE system dynamically gains and loses relevance to regulate inhibitory control under different responding modes [237]. This work has led to the use of the NE-specific reuptake inhibitor atomoxetine as a treatment of pediatric attention-deficit/hyperactivity disorder (ADHD) [235]. Furthermore, it is demonstrated that ADHD patients have a higher positron emission tomography (PET)-measured NET availability in comparison to healthy individuals, suggesting that there are underlying genetic and epigenetic mechanisms.

5. Functional Interplay between the Cholinergic and Noradrenergic Systems

5.1. ACh and NE in Attention

It has been widely acknowledged that both cholinergic and noradrenergic systems show graded and transient increases in their response to increased attention to environmental cues [238,239,240]. Noradrenergic axon activity starts ~1 s prior to the peak of pupil dilation, while cholinergic axion activity lags ~0.5 s behind the peak, suggesting pupil-linked alertness, attention, and mental effort are controlled differentially by the two neuromodulatory transmitter systems [241]. Studies have shown that basal forebrain and brainstem cholinergic systems interact differently with the LC-NE system related to attention [42,242]. It was demonstrated that sustained attentional performance necessarily requires the integrity of BF cholinergic projections but not their noradrenergic afferents [243,244]. However, for thalamocortical information processing, ACh activation produces a noisy broadband signal detection mode, while NE activation sets to a noise-free high-frequency signal detection mode, which seems to be more optimized for selective attention than brainstem cholinergic activation [242].
Generally, cortical ACh–NE interaction plays a significant role in the modulation of attention [245,246,247]. Using fluorescent retrograde tracers in ACC, mPFC, and OFC, it was uncovered that subsets of LC neurons might be responsible for modulating individual prefrontal subregions independently, yet subsets of NB neurons might produce universal influence in prefrontal subregions [245], providing insight respecting prefrontal cortex’s role of allocating attentional reserves. In an attentional set shifting task, McGaughy and colleagues pointed out that the specific impairments in animals’ ability to shift attentional set were produced by noradrenergic instead of cholinergic deafferentation in the prefrontal cortex [247]. Indeed, the cortical cholinergic system is very likely to be involved in aspects of established attentional performance, while the NE system is more competent in detecting shifts in the predictive relationship between action and reinforcement [246].
Future studies are highly encouraged to explore the ACh–NE interaction in the contexts of their complementary roles regarding attention modulation. The systematic characterization and manipulation of the cholinergic and NE projections at biochemical, genetic, pharmacological, and physiological levels would largely facilitate our understanding of the interaction between the two systems and inform the development of potential therapeutics for certain neurodegenerative and psychiatric diseases.

5.2. ACh and NE in Learning and Decision Making

The interplay between the noradrenergic and cholinergic systems in the decision making and learning processes is highly complex. Each neuromodulatory system plays a pivotal role in creating these complex cognitive brain states, integrating sensory information with positive and negative feedback loops through multiple brain regions. For example, the visual system of a macaque primate has integration and circuitry across all neuromodulators, inhibiting and exciting different neurons, changing gene expression, and modulating synaptic circuitry [248]. Due to the complexity of decision making, the unpredictability of environments, and the uncertainty of risk-taking during exploration, the relationship between neuromodulators is not yet well understood [249]. Even with this challenge, there have been studies that have attempted to look at isolated NE and ACh interaction in specific decision-making tasks. In isolated behaviors, specific neuromodulators can be seen to regulate specific sub-tasks. In meta learning, NE can be seen to contribute to the randomness of action selection, while ACh seems to solely dictate the speed of specific memory updates [185]. Both neuromodulators have also been implicated in the information transmission during different behaviors [19,250]. Theoretical modeling has been used to further understand the role both NE and ACh play in uncertainty, behaving both synergistically and antagonistically, enabling complex learning in challenging adaptive environments [251] Understanding how both of these neuromodulators interact with one another in a variety of decision making and learning paradigms will be critical for developing translational treatments for neurological conditions that involve these neurotransmitters.

6. Future Directions

The functional consequences of overlapping and interacting neuromodulatory systems are as numerous as they are behaviorally important. An understanding has been slowly emerging over at least two decades that a diversity of functionally distinct circuits and heterogeneously distributed receptor subpopulations between neuromodulatory systems gives rise to many of the most interesting aspects of neural processing and adaptive behavioral outcomes. However, the differential influence of each neuromodulator on a specific circuit of interest is highly complex and requires a very careful experimental framework in order to begin unraveling a more complete understanding of the influence of ACh and NE on specific behaviors. As has been demonstrated by the work covered in this review, overlapping, segmented receptive fields, non-uniform receptor distributions and the wide range of actions of ACh and NE, in a spatially and temporally dependent manner, make broad conclusions about each system difficult to generalize. It is critical for future work to use a modern arsenal of tools to dissect the role of these two systems in isolated circuits that have important behavioral relevance.
Given the highly region-dependent action of these neuromodulatory systems, future work may begin with the identification and isolation of a specific target. An example of such an isolation would be to examine the role of the regions comprising the mPFC in decision making [175,252,253,254,255]. In order to understand the possible functional role of ACh and NE in modulating these regions, experiments should be devised to further characterize noradrenergic and cholinergic inputs to the mPFC. Initial experiments should also provide a basic characterization of the density and distribution of cholinergic and noradrenergic receptors in the target region using either traditional receptor expression profiling tools or the integration of new tools such as spatial single cell sequencing. Once the neuromodulatory input into the region of interest has been quantified and the range of receptors expressed summarized, an experimental framework can be established to systematically isolate one variable at a time.
In this framework, a functionally important region of the cortex can be isolated with respect to its neuromodulatory input, and the relevant molecular targets identified. At this point, the systematic exploration of the release of NE and ACh in a representative behavioral task will provide the foundation for understanding the differential presence of each system in the specified brain region during normal behavior. More sophisticated single-unit electrophysiology or calcium imaging experiments that explore the change in network dynamics in response to neuromodulator release can be paired with selective cholinergic and noradrenergic activation or silencing to observe the response not only of the animal and the neuronal connectivity but also the response of the other neurotransmitter system. Systematic knockouts or the implementation of inducible/repressible receptor expression in the specified region will also provide insights into how functional modules in the cortex are regulated by multiple neuromodulators.
The result of conducting many of these experiments in parallel will be an improved understanding of how broadly acting neuromodulator networks contribute to subdivided, and not necessarily unified, responses throughout the brain. Understanding the influence of ACh and NE on specific modules, and the afferent source of these neuromodulators, will provide improved targets for functional neural stimulation and greater degrees of freedom for higher bandwidth communication and dynamic network control through neural interfaces [256].

7. Conclusions

The cholinergic and noradrenergic modulation of functionally distinct regions of the brain has become one of the primary organizational principles behind understanding the contribution of each system to the diversity of neural computation in the central nervous system. Decades of work has shown that a diverse family of receptors, which stratify across different brain regions, and afferent and efferent projections that can be selectively activated, are critical in helping widespread neuromodulatory systems obtain substantial heterogeneity in the sophistication of their role in neural processes. The result of such a complicated interplay between two diffuse modulatory systems is a dynamic and highly context-dependent role for brain regions important in learning, memory, attention, and decision making. To further improve our understanding of these systems, it is essential to adopt approaches that are built on previous work to identify the interplay, at the receptor, circuit, and functional levels, between these systems in an isolated circuit that can be tied to a behaviorally functional outcome. The results will allow greater understanding and control over wide-ranging behaviors.

Funding

This research was funded by NIH R01MH112267, R01NS119813, R01AG075114, R21MH125107, and NSF CBET 1847315.

Disclaimer

Q.W. is the co-founder of Sharper Sense, a company developing methods of enhancing sensory processing with neural interfaces.

References

  1. Bianconi, E.; Piovesan, A.; Facchin, F.; Beraudi, A.; Casadei, R.; Frabetti, F.; Vitale, L.; Pelleri, M.C.; Tassani, S.; Piva, F.; et al. An estimation of the number of cells in the human body. Ann. Hum. Biol. 2013, 40, 463–471. [Google Scholar] [CrossRef]
  2. Newman, E.A. New roles for astrocytes: Regulation of synaptic transmission. Trends Neurosci. 2003, 26, 536–542. [Google Scholar] [CrossRef]
  3. Marinelli, S.; Basilico, B.; Marrone, M.C.; Ragozzino, D. Microglia-neuron crosstalk: Signaling mechanism and control of synaptic transmission. Semin. Cell Dev. Biol. 2019, 94, 138–151. [Google Scholar] [CrossRef]
  4. Hyman, S.E. Neurotransmitters. Curr. Biol. 2005, 15, R154–R158. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Nedergaard, M.; Takano, T.; Hansen, A.J. Beyond the role of glutamate as a neurotransmitter. Nat. Rev. Neurosci. 2002, 3, 748–755. [Google Scholar] [CrossRef] [PubMed]
  6. Owens, D.F.; Kriegstein, A.R. Is there more to GABA than synaptic inhibition? Nat. Rev. Neurosci. 2002, 3, 715–727. [Google Scholar] [CrossRef] [PubMed]
  7. Kurcyus, K.; Annac, E.; Hanning, N.M.; Harris, A.D.; Oeltzschner, G.; Edden, R.; Riedl, V. Opposite Dynamics of GABA and Glutamate Levels in the Occipital Cortex during Visual Processing. J. Neurosci. 2018, 38, 9967–9976. [Google Scholar] [CrossRef]
  8. Carlsson, A.; Waters, N.; Holm-Waters, S.; Tedroff, J.; Nilsson, M.; Carlsson, M.L. Interactions Between Monoamines, Glutamate, and GABA in Schizophrenia: New Evidence. Annu. Rev. Pharmacol. Toxicol. 2001, 41, 237–260. [Google Scholar] [CrossRef]
  9. Marmigere, F.; Rage, F.; Tapia-Arancibia, L. GABA-glutamate interaction in the control of BDNF expression in hypothalamic neurons. Neurochem. Int. 2003, 42, 353–358. [Google Scholar] [CrossRef]
  10. Katz, P.; Edwards, D. Beyond Neurotransmission; Oxford University Press: New York, NY, USA, 1999. [Google Scholar]
  11. Agnati, L.F.; Leo, G.; Zanardi, A.; Genedani, S.; Rivera, A.; Fuxe, K.; Guidolin, D. Volume transmission and wiring transmission from cellular to molecular networks: History and perspectives. Acta Physiol. 2006, 187, 329–344. [Google Scholar] [CrossRef]
  12. Zaborszky, L. The modular organization of brain systems. Basal forebrain: The last frontier. In Progress in Brain Research; Elsevier: Amsterdam, The Netherlands, 2002; Volume 136, pp. 359–372. [Google Scholar]
  13. Golmayo, L.; Nunez, A.; Zaborszky, L. Electrophysiological evidence for the existence of a posterior cortical-prefrontal-basal forebrain circuitry in modulating sensory responses in visual and somatosensory rat cortical areas. Neuroscience 2003, 119, 597–609. [Google Scholar] [CrossRef]
  14. Briand, L.A.; Gritton, H.; Howe, W.M.; Young, D.A.; Sarter, M. Modulators in concert for cognition: Modulator interactions in the prefrontal cortex. Prog. Neurobiol. 2007, 83, 69–91. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Blokland, A. Acetylcholine: A neurotransmitter for learning and memory? Brain Res. Rev. 1995, 21, 285–300. [Google Scholar] [CrossRef]
  16. Sarter, M.; Bruno, J.P. Cognitive functions of cortical acetylcholine: Toward a unifying hypothesis. Brain Res. Brain Res. Rev. 1997, 23, 28–46. [Google Scholar] [CrossRef]
  17. Parikh, V.; Kozak, R.; Martinez, V.; Sarter, M. Prefrontal acetylcholine release controls cue detection on multiple timescales. Neuron 2007, 56, 141–154. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  18. Goard, M.; Dan, Y. Basal forebrain activation enhances cortical coding of natural scenes. Nat. Neurosci. 2009, 12, 1444–1449. [Google Scholar] [CrossRef]
  19. Rodenkirch, C.; Wang, Q. Rapid and transient enhancement of thalamic information transmission induced by vagus nerve stimulation. J. Neural. Eng. 2020, 17, 026027. [Google Scholar] [CrossRef]
  20. Rodenkirch, C.; Liu, Y.; Schriver, B.J.; Wang, Q. Locus coeruleus activation enhances thalamic feature selectivity via norepinephrine regulation of intrathalamic circuit dynamics. Nat. Neurosci. 2019, 22, 120–133. [Google Scholar] [CrossRef]
  21. Schwarz, L.A.; Luo, L. Organization of the locus coeruleus-norepinephrine system. Curr. Biol. 2015, 25, R1051–R1056. [Google Scholar] [CrossRef] [Green Version]
  22. Devilbiss, D.M.; Page, M.E.; Waterhouse, B.D. Locus Ceruleus Regulates Sensory Encoding by Neurons and Networks in Waking Animals. J. Neurosci. 2006, 26, 9860–9872. [Google Scholar] [CrossRef]
  23. Vazey, E.M.; Moorman, D.E.; Aston-Jones, G. Phasic locus coeruleus activity regulates cortical encoding of salience information. Proc. Natl. Acad. Sci. USA 2018, 115, E9439. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Yang, H.; Bari, B.A.; Cohen, J.Y.; O’Connor, D.H. Locus coeruleus spiking differently correlates with S1 cortex activity and pupil diameter in a tactile detection task. eLife 2021, 10, e64327. [Google Scholar] [CrossRef]
  25. Liu, Y.; Narasimhan, S.; Schriver, B.J.; Wang, Q. Perceptual Behavior Depends Differently on Pupil-Linked Arousal and Heartbeat Dynamics-Linked Arousal in Rats Performing Tactile Discrimination Tasks. Front. Syst. Neurosci. 2021, 14, 614248. [Google Scholar] [CrossRef] [PubMed]
  26. O’Dell, T.J.; Connor, S.A.; Guglietta, R.; Nguyen, P.V. beta-Adrenergic receptor signaling and modulation of long-term potentiation in the mammalian hippocampus. Learn Mem. 2015, 22, 461–471. [Google Scholar] [CrossRef] [Green Version]
  27. Spencer, R.C.; Berridge, C.W. Receptor and circuit mechanisms underlying differential procognitive actions of psychostimulants. Neuropsychopharmacology 2019, 44, 1820–1827. [Google Scholar] [CrossRef]
  28. Usher, M.; Cohen, J.D.; Servan-Schreiber, D.; Rajkowski, J.; Aston-Jones, G. The Role of Locus Coeruleus in the Regulation of Cognitive Performance. Science 1999, 283, 549–554. [Google Scholar] [CrossRef] [PubMed]
  29. Janitzky, K.; Lippert, M.T.; Engelhorn, A.; Tegtmeier, J.; Goldschmidt, J.; Heinze, H.-J.; Ohl, F.W. Optogenetic silencing of locus coeruleus activity in mice impairs cognitive flexibility in an attentional set-shifting task. Front. Behav. Neurosci. 2015, 9, 286. [Google Scholar] [CrossRef] [Green Version]
  30. Aston-Jones, G.; Rajkowski, J.; Cohen, J. Locus coeruleus and regulation of behavioral flexibility and attention. In Progress in Brain Research; Uylings, H.B.M., Eden, G.G.V., Bruin, J.P.C.D., Feenstra, M.G.P., Pennartz, C.M.A., Eds.; Elsevier: Amsterdam, The Netherlands, 2000; Volume 126, pp. 165–182. [Google Scholar]
  31. Kalwani, R.M.; Joshi, S.; Gold, J.I. Phasic Activation of Individual Neurons in the Locus Ceruleus/Subceruleus Complex of Monkeys Reflects Rewarded Decisions to Go But Not Stop. J. Neurosci. 2014, 34, 13656–13669. [Google Scholar] [CrossRef] [Green Version]
  32. Schriver, B.; Bagdasarov, S.; Wang, Q. Pupil-linked arousal modulates behavior in rats performing a whisker deflection direction discrimination task. J. Neurophysiol. 2018, 120, 1655–1670. [Google Scholar] [CrossRef] [Green Version]
  33. Schriver, B.J.; Perkins, S.M.; Sajda, P.; Wang, Q. Interplay between components of pupil-linked phasic arousal and its role in driving behavioral choice in Go/No-Go perceptual decision-making. Psychophysiology 2020, 57, e13565. [Google Scholar] [CrossRef]
  34. Slater, C.; Wang, Q. Alzheimer’s disease: An evolving understanding of noradrenergic involvement and the promising future of electroceutical therapies. Clin. Transl. Med. 2021, 11, e397. [Google Scholar] [CrossRef] [PubMed]
  35. Furey, M.L. The prominent role of stimulus processing: Cholinergic function and dysfunction in cognition. Curr. Opin. Neurol. 2011, 24, 364–370. [Google Scholar] [CrossRef] [Green Version]
  36. Bohnen, N.I.; Albin, R.L. The cholinergic system and Parkinson disease. Behav. Brain Res. 2011, 221, 564–573. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Yamamoto, K.-i.; Shinba, T.; Yoshii, M. Psychiatric symptoms of noradrenergic dysfunction: A pathophysiological view. Psychiatry Clin. Neurosci. 2014, 68, 1–20. [Google Scholar] [CrossRef] [PubMed]
  38. Marien, M.R.; Colpaert, F.C.; Rosenquist, A.C. Noradrenergic mechanisms in neurodegenerative diseases: A theory. Brain Res. Rev. 2004, 45, 38–78. [Google Scholar] [CrossRef]
  39. Doppler, C.E.J.; Smit, J.A.M.; Hommelsen, M.; Seger, A.; Horsager, J.; Kinnerup, M.B.; Hansen, A.K.; Fedorova, T.D.; Knudsen, K.; Otto, M.; et al. Microsleep disturbances are associated with noradrenergic dysfunction in Parkinson’s disease. Sleep 2021, 44, zsab040. [Google Scholar] [CrossRef]
  40. Weinshenker, D. Long Road to Ruin: Noradrenergic Dysfunction in Neurodegenerative Disease. Trends Neurosci. 2018, 41, 211–223. [Google Scholar] [CrossRef]
  41. Gannon, M.; Che, P.; Chen, Y.; Jiao, K.; Roberson, E.D.; Wang, Q. Noradrenergic dysfunction in Alzheimer’s disease. Front. Neurosci. 2015, 9, 220. [Google Scholar] [CrossRef] [Green Version]
  42. Sarter, M.; Bruno, J.P. Cortical cholinergic inputs mediating arousal, attentional processing and dreaming: Differential afferent regulation of the basal forebrain by telencephalic and brainstem afferents. Neuroscience 1999, 95, 933–952. [Google Scholar] [CrossRef]
  43. Lehmann, J.; Nagy, J.I.; Atmadia, S.; Fibiger, H.C. The nucleus basalis magnocellularis: The origin of a cholinergic projection to the neocortex of the rat. Neuroscience 1980, 5, 1161–1174. [Google Scholar] [CrossRef]
  44. Levey, A.I.; Hallanger, A.E.; Wainer, B.H. Cholinergic nucleus basalis neurons may influence the cortex via the thalamus. Neurosci. Lett. 1987, 74, 7–13. [Google Scholar] [CrossRef]
  45. Bergado, J.A.; Frey, S.; Lopez, J.; Almaguer-Melian, W.; Frey, J.U. Cholinergic afferents to the locus coeruleus and noradrenergic afferents to the medial septum mediate LTP-reinforcement in the dentate gyrus by stimulation of the amygdala. Neurobiol. Learn Mem 2007, 88, 331–341. [Google Scholar] [CrossRef] [PubMed]
  46. Satoh, K.; Fibiger, H.C. Cholinergic neurons of the laterodorsal tegmental nucleus: Efferent and afferent connections. J. Comp. Neurol. 1986, 253, 277–302. [Google Scholar] [CrossRef] [PubMed]
  47. Mesulam, M.M. Cholinergic circuitry of the human nucleus basalis and its fate in Alzheimer’s disease. J. Comp. Neurol. 2013, 521, 4124–4144. [Google Scholar] [CrossRef] [Green Version]
  48. Higo, S.; Matsuyama, T.; Kawamura, S. Direct projections from the pedunculopontine and laterodorsal tegmental nuclei to area 17 of the visual cortex in the cat. Neurosci. Res. 1996, 26, 109–118. [Google Scholar] [CrossRef]
  49. Bloem, B.; Schoppink, L.; Rotaru, D.C.; Faiz, A.; Hendriks, P.; Mansvelder, H.D.; van de Berg, W.D.; Wouterlood, F.G. Topographic mapping between basal forebrain cholinergic neurons and the medial prefrontal cortex in mice. J. Neurosci. 2014, 34, 16234–16246. [Google Scholar] [CrossRef] [Green Version]
  50. Li, X.; Yu, B.; Sun, Q.; Zhang, Y.; Ren, M.; Zhang, X.; Li, A.; Yuan, J.; Madisen, L.; Luo, Q.; et al. Generation of a whole-brain atlas for the cholinergic system and mesoscopic projectome analysis of basal forebrain cholinergic neurons. Proc. Natl. Acad. Sci. USA 2018, 115, 415–420. [Google Scholar] [CrossRef] [Green Version]
  51. Woolf, N.J. Cholinergic systems in mammalian brain and spinal cord. Prog. Neurobiol. 1991, 37, 475–524. [Google Scholar] [CrossRef]
  52. Rye, D.B.; Wainer, B.H.; Mesulam, M.M.; Mufson, E.J.; Saper, C.B. Cortical projections arising from the basal forebrain: A study of cholinergic and noncholinergic components employing combined retrograde tracing and immunohistochemical localization of choline acetyltransferase. Neuroscience 1984, 13, 627–643. [Google Scholar] [CrossRef]
  53. Kaneko, S.; Hikida, T.; Watanabe, D.; Ichinose, H.; Nagatsu, T.; Kreitman, R.J.; Pastan, I.; Nakanishi, S. Synaptic integration mediated by striatal cholinergic interneurons in basal ganglia function. Science 2000, 289, 633–637. [Google Scholar] [CrossRef] [Green Version]
  54. Bickford, M.E.; Gunluk, A.E.; Van Horn, S.C.; Sherman, S.M. GABAergic projection from the basal forebrain to the visual sector of the thalamic reticular nucleus in the cat. J. Comp. Neurol. 1994, 348, 481–510. [Google Scholar] [CrossRef] [PubMed]
  55. van der Zee, E.A.; Luiten, P.G. Muscarinic acetylcholine receptors in the hippocampus, neocortex and amygdala: A review of immunocytochemical localization in relation to learning and memory. Prog. Neurobiol. 1999, 58, 409–471. [Google Scholar] [CrossRef]
  56. Kim, J.-H.; Jung, A.-H.; Jeong, D.; Choi, I.; Kim, K.; Shin, S.; Kim, S.J.; Lee, S.-H. Selectivity of Neuromodulatory Projections from the Basal Forebrain and Locus Ceruleus to Primary Sensory Cortices. J. Neurosci. 2016, 36, 5314–5327. [Google Scholar] [CrossRef] [PubMed]
  57. Chavez, C.; Zaborszky, L. Basal Forebrain Cholinergic-Auditory Cortical Network: Primary Versus Nonprimary Auditory Cortical Areas. Cereb Cortex 2017, 27, 2335–2347. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  58. Fournier, G.N.; Semba, K.; Rasmusson, D.D. Modality- and region-specific acetylcholine release in the rat neocortex. Neuroscience 2004, 126, 257–262. [Google Scholar] [CrossRef]
  59. Liu, A.K.L.; Gentleman, S.M. The diagonal band of Broca in health and disease. In Handbook of Clinical Neurology; Swaab, D.F., Kreier, F., Lucassen, P.J., Salehi, A., Buijs, R.M., Eds.; Elsevier: Amsterdam, The Netherlands, 2021; Volume 179, pp. 175–187. [Google Scholar]
  60. Mechawar, N.; Cozzari, C.; Descarries, L. Cholinergic innervation in adult rat cerebral cortex: A quantitative immunocytochemical description. J. Comp. Neurol. 2000, 428, 305–318. [Google Scholar] [CrossRef]
  61. Smiley, J.F.; Mesulam, M.M. Cholinergic neurons of the nucleus basalis of Meynert receive cholinergic, catecholaminergic and GABAergic synapses: An electron microscopic investigation in the monkey. Neuroscience 1999, 88, 241–255. [Google Scholar] [CrossRef]
  62. Mesulam, M.M. The cholinergic innervation of the human cerebral cortex. Prog. Brain Res. 2004, 145, 67–78. [Google Scholar] [CrossRef]
  63. Samuels, E.R.; Szabadi, E. Functional neuroanatomy of the noradrenergic locus coeruleus: Its roles in the regulation of arousal and autonomic function part II: Physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans. Curr. Neuropharmacol. 2008, 6, 254–285. [Google Scholar] [CrossRef] [Green Version]
  64. Jones, B.E.; Cuello, A.C. Afferents to the basal forebrain cholinergic cell area from pontomesencephalic--catecholamine, serotonin, and acetylcholine--neurons. Neuroscience 1989, 31, 37–61. [Google Scholar] [CrossRef]
  65. Khateb, A.; Fort, P.; Williams, S.; Serafin, M.; Muhlethaler, M.; Jones, B.E. GABAergic input to cholinergic nucleus basalis neurons. Neuroscience 1998, 86, 937–947. [Google Scholar] [CrossRef]
  66. Rodriguez-Garcia, G.; Miranda, M.I. Opposing Roles of Cholinergic and GABAergic Activity in the Insular Cortex and Nucleus Basalis Magnocellularis during Novel Recognition and Familiar Taste Memory Retrieval. J. Neurosci. 2016, 36, 1879–1889. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  67. Casamenti, F.; Deffenu, G.; Abbamondi, A.L.; Pepeu, G. Changes in cortical acetylcholine output induced by modulation of the nucleus basalis. Brain Res. Bull 1986, 16, 689–695. [Google Scholar] [CrossRef]
  68. Semba, K.; Reiner, P.B.; McGeer, E.G.; Fibiger, H.C. Brainstem afferents to the magnocellular basal forebrain studied by axonal transport, immunohistochemistry, and electrophysiology in the rat. J. Comp. Neurol. 1988, 267, 433–453. [Google Scholar] [CrossRef]
  69. Semba, K.; Fibiger, H.C. Afferent connections of the laterodorsal and the pedunculopontine tegmental nuclei in the rat: A retro- and antero-grade transport and immunohistochemical study. J. Comp. Neurol. 1992, 323, 387–410. [Google Scholar] [CrossRef]
  70. Brudzynski, S.M.; Kadishevitz, L.; Fu, X.W. Mesolimbic component of the ascending cholinergic pathways: Electrophysiological-pharmacological study. J. Neurophysiol. 1998, 79, 1675–1686. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  71. Martinez-Gonzalez, C.; Bolam, J.P.; Mena-Segovia, J. Topographical organization of the pedunculopontine nucleus. Front. Neuroanat. 2011, 5, 22. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  72. Matsumura, M.; Nambu, A.; Yamaji, Y.; Watanabe, K.; Imai, H.; Inase, M.; Tokuno, H.; Takada, M. Organization of somatic motor inputs from the frontal lobe to the pedunculopontine tegmental nucleus in the macaque monkey. Neuroscience 2000, 98, 97–110. [Google Scholar] [CrossRef]
  73. Schofield, B.R.; Motts, S.D. Projections from auditory cortex to cholinergic cells in the midbrain tegmentum of guinea pigs. Brain Res. Bull 2009, 80, 163–170. [Google Scholar] [CrossRef] [Green Version]
  74. Florio, T.; Scarnati, E.; Confalone, G.; Minchella, D.; Galati, S.; Stanzione, P.; Stefani, A.; Mazzone, P. High-frequency stimulation of the subthalamic nucleus modulates the activity of pedunculopontine neurons through direct activation of excitatory fibres as well as through indirect activation of inhibitory pallidal fibres in the rat. Eur. J. Neurosci. 2007, 25, 1174–1186. [Google Scholar] [CrossRef]
  75. Granata, A.R.; Kitai, S.T. Intracellular analysis of excitatory subthalamic inputs to the pedunculopontine neurons. Brain Res 1989, 488, 57–72. [Google Scholar] [CrossRef]
  76. Granata, A.R.; Kitai, S.T. Inhibitory substantia nigra inputs to the pedunculopontine neurons. Exp. Brain Res. 1991, 86, 459–466. [Google Scholar] [CrossRef] [PubMed]
  77. Hammond, C.; Rouzaire-Dubois, B.; Feger, J.; Jackson, A.; Crossman, A.R. Anatomical and electrophysiological studies on the reciprocal projections between the subthalamic nucleus and nucleus tegmenti pedunculopontinus in the rat. Neuroscience 1983, 9, 41–52. [Google Scholar] [CrossRef]
  78. Smith, Y.; Bolam, J.P.; Von Krosigk, M. Topographical and Synaptic Organization of the GABA-Containing Pallidosubthalamic Projection in the Rat. Eur. J. Neurosci. 1990, 2, 500–511. [Google Scholar] [CrossRef]
  79. Moriizumi, T.; Hattori, T. Separate neuronal populations of the rat globus pallidus projecting to the subthalamic nucleus, auditory cortex and pedunculopontine tegmental area. Neuroscience 1992, 46, 701–710. [Google Scholar] [CrossRef]
  80. Haber, S.N.; Lynd, E.; Klein, C.; Groenewegen, H.J. Topographic organization of the ventral striatal efferent projections in the rhesus monkey: An anterograde tracing study. J. Comp. Neurol. 1990, 293, 282–298. [Google Scholar] [CrossRef]
  81. Noda, T.; Oka, H. Nigral inputs to the pedunculopontine region: Intracellular analysis. Brain Res 1984, 322, 332–336. [Google Scholar] [CrossRef]
  82. Jones, B.E.; Yang, T.Z. The efferent projections from the reticular formation and the locus coeruleus studied by anterograde and retrograde axonal transport in the rat. J. Comp. Neurol. 1985, 242, 56–92. [Google Scholar] [CrossRef]
  83. Steininger, T.L.; Rye, D.B.; Wainer, B.H. Afferent projections to the cholinergic pedunculopontine tegmental nucleus and adjacent midbrain extrapyramidal area in the albino rat. I. Retrograde tracing studies. J. Comp. Neurol. 1992, 321, 515–543. [Google Scholar] [CrossRef]
  84. Segal, M. Brain stem afferents to the rat medial septum. J. Physiol. 1976, 261, 617–631. [Google Scholar] [CrossRef] [Green Version]
  85. Vertes, R.P. Brainstem afferents to the basal forebrain in the rat. Neuroscience 1988, 24, 907–935. [Google Scholar] [CrossRef]
  86. Borhegyi, Z.; Magloczky, Z.; Acsady, L.; Freund, T.F. The supramammillary nucleus innervates cholinergic and GABAergic neurons in the medial septum-diagonal band of Broca complex. Neuroscience 1998, 82, 1053–1065. [Google Scholar] [CrossRef]
  87. Steriade, M.; Datta, S.; Pare, D.; Oakson, G.; Curro Dossi, R.C. Neuronal activities in brain-stem cholinergic nuclei related to tonic activation processes in thalamocortical systems. J. Neurosci. 1990, 10, 2541–2559. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  88. Steriade, M.; Parent, A.; Pare, D.; Smith, Y. Cholinergic and non-cholinergic neurons of cat basal forebrain project to reticular and mediodorsal thalamic nuclei. Brain Res. 1987, 408, 372–376. [Google Scholar] [CrossRef]
  89. Mesulam, M.M.; Mufson, E.J.; Levey, A.I.; Wainer, B.H. Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. J. Comp. Neurol. 1983, 214, 170–197. [Google Scholar] [CrossRef]
  90. Steckler, T.; Inglis, W.; Winn, P.; Sahgal, A. The pedunculopontine tegmental nucleus: A role in cognitive processes? Brain Res. Brain Res. Rev. 1994, 19, 298–318. [Google Scholar] [CrossRef]
  91. Mena-Segovia, J.; Bolam, J.P. Rethinking the Pedunculopontine Nucleus: From Cellular Organization to Function. Neuron 2017, 94, 7–18. [Google Scholar] [CrossRef] [Green Version]
  92. Kami, K.; Tajima, F.; Senba, E. Activation of mesolimbic reward system via laterodorsal tegmental nucleus and hypothalamus in exercise-induced hypoalgesia. Sci. Rep. 2018, 8, 11540. [Google Scholar] [CrossRef] [Green Version]
  93. Grzanna, R.; Molliver, M.E. The locus coeruleus in the rat: An immunohistochemical delineation. Neuroscience 1980, 5, 21–40. [Google Scholar] [CrossRef]
  94. Swanson, L.W.; Hartman, B.K. The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-beta-hydroxylase as a marker. J. Comp. Neurol. 1975, 163, 467–505. [Google Scholar] [CrossRef]
  95. Sara, S.J.; Bouret, S. Orienting and reorienting: The locus coeruleus mediates cognition through arousal. Neuron 2012, 76, 130–141. [Google Scholar] [CrossRef] [Green Version]
  96. Foote, S.L.; Bloom, F.E.; Aston-Jones, G. Nucleus locus ceruleus: New evidence of anatomical and physiological specificity. Physiol. Rev. 1983, 63, 844–914. [Google Scholar] [CrossRef] [PubMed]
  97. Dahlström, A.; Fuxe, K. Demonstration of Monoamines in the Cell Bodies of Brain Stem Neurons; Almqvist & Wiksell: Uppsala, Sweden, 1964. [Google Scholar]
  98. Poe, G.R.; Foote, S.; Eschenko, O.; Johansen, J.P.; Bouret, S.; Aston-Jones, G.; Harley, C.W.; Manahan-Vaughan, D.; Weinshenker, D.; Valentino, R.; et al. Locus coeruleus: A new look at the blue spot. Nat. Rev. Neurosci. 2020, 21, 644–659. [Google Scholar] [CrossRef] [PubMed]
  99. Fallon, J.H.; Koziell, D.A.; Moore, R.Y. Catecholamine innervation of the basal forebrain. II. Amygdala, suprarhinal cortex and entorhinal cortex. J. Comp. Neurol. 1978, 180, 509–532. [Google Scholar] [CrossRef] [PubMed]
  100. Morrison, J.H.; Molliver, M.E.; Grzanna, R.; Coyle, J.T. Noradrenergic innervation patterns in three regions of medial cortex: An immunofluorescence characterization. Brain Res Bull 1979, 4, 849–857. [Google Scholar] [CrossRef]
  101. Berridge, C.W.; Waterhouse, B.D. The locus coeruleus-noradrenergic system: Modulation of behavioral state and state-dependent cognitive processes. Brain Res. Brain Res. Rev. 2003, 42, 33–84. [Google Scholar] [CrossRef]
  102. Agster, K.L.; Mejias-Aponte, C.A.; Clark, B.D.; Waterhouse, B.D. Evidence for a regional specificity in the density and distribution of noradrenergic varicosities in rat cortex. J. Comp. Neurol. 2013, 521, 2195–2207. [Google Scholar] [CrossRef] [Green Version]
  103. Giustino, T.F.; Maren, S. Noradrenergic Modulation of Fear Conditioning and Extinction. Front. Behav. Neurosci. 2018, 12, 43. [Google Scholar] [CrossRef]
  104. Jänig, W. Integrative Action of the Autonomic Nervous System: Neurobiology of Homeostasis; Cambridge University Press: Cambridge, UK, 2006. [Google Scholar]
  105. Farmer, D.G.S.; Pracejus, N.; Dempsey, B.; Turner, A.; Bokiniec, P.; Paton, J.F.R.; Pickering, A.E.; Burguet, J.; Andrey, P.; Goodchild, A.K.; et al. On the presence and functional significance of sympathetic premotor neurons with collateralized spinal axons in the rat. J. Physiol. 2019, 597, 3407–3423. [Google Scholar] [CrossRef]
  106. Totah, N.K.B.; Logothetis, N.K.; Eschenko, O. Noradrenergic ensemble-based modulation of cognition over multiple timescales. Brain Res. 2019, 1709, 50–66. [Google Scholar] [CrossRef]
  107. Shipley, M.T.; Fu, L.; Ennis, M.; Liu, W.-L.; Aston-Jones, G. Dendrites of locus coeruleus neurons extend preferentially into two pericoerulear zones. J. Comp. Neurol. 1996, 365, 56–68. [Google Scholar] [CrossRef]
  108. Schwarz, L.A.; Miyamichi, K.; Gao, X.J.; Beier, K.T.; Weissbourd, B.; DeLoach, K.E.; Ren, J.; Ibanes, S.; Malenka, R.C.; Kremer, E.J.; et al. Viral-genetic tracing of the input-output organization of a central noradrenaline circuit. Nature 2015, 524, 88–92. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  109. Totah, N.K.; Neves, R.M.; Panzeri, S.; Logothetis, N.K.; Eschenko, O. The Locus Coeruleus Is a Complex and Differentiated Neuromodulatory System. Neuron 2018, 99, 1055–1068.e1056. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  110. Aston-Jones, G.; Ennis, M.; Pieribone, V.A.; Nickell, W.T.; Shipley, M.T. The brain nucleus locus coeruleus: Restricted afferent control of a broad efferent network. Science 1986, 234, 734–737. [Google Scholar] [CrossRef] [PubMed]
  111. Cedarbaum, J.M.; Aghajanian, G.K. Afferent projections to the rat locus coeruleus as determined by a retrograde tracing technique. J. Comp. Neurol. 1978, 178, 1–15. [Google Scholar] [CrossRef]
  112. Aston-Jones, G.; Shipley, M.T.; Chouvet, G.; Ennis, M.; van Bockstaele, E.; Pieribone, V.; Shiekhattar, R.; Akaoka, H.; Drolet, G.; Astier, B.; et al. Afferent regulation of locus coeruleus neurons: Anatomy, physiology and pharmacology. In Progress in Brain Research; Barnes, C.D., Pompeiano, O., Eds.; Elsevier: Amsterdam, The Netherlands, 1991; Volume 88, pp. 47–75. [Google Scholar]
  113. De Cicco, V.; Tramonti Fantozzi, M.P.; Cataldo, E.; Barresi, M.; Bruschini, L.; Faraguna, U.; Manzoni, D. Trigeminal, Visceral and Vestibular Inputs May Improve Cognitive Functions by Acting through the Locus Coeruleus and the Ascending Reticular Activating System: A New Hypothesis. Front. Neuroanat. 2018, 11, 130. [Google Scholar] [CrossRef]
  114. Tramonti Fantozzi, M.P.; De Cicco, V.; Argento, S.; De Cicco, D.; Barresi, M.; Cataldo, E.; Bruschini, L.; d’Ascanio, P.; Faraguna, U.; Manzoni, D. Trigeminal input, pupil size and cognitive performance: From oral to brain matter. Brain Res. 2021, 1751, 147194. [Google Scholar] [CrossRef]
  115. Rodenkirch, C.; Carmel, J.; Wang, Q. Rapid Effects of Vagus Nerve Stimulation on Sensory Processing Through Activation of Neuromodulatory Systems. Front. Neurosci. 2022, 16. [Google Scholar] [CrossRef]
  116. Tramonti Fantozzi, M.P.; De Cicco, V.; De Cicco, D.; d’Ascanio, P.; Cataldo, E.; Bruschini, L.; Faraguna, U.; Manzoni, D. Chewing and Cognitive Improvement: The Side Matters. Front. Syst. Neurosci. 2021, 15, 158. [Google Scholar] [CrossRef]
  117. Luppi, P.H.; Aston-Jones, G.; Akaoka, H.; Chouvet, G.; Jouvet, M. Afferent projections to the rat locus coeruleus demonstrated by retrograde and anterograde tracing with cholera-toxin B subunit and Phaseolus vulgaris leucoagglutinin. Neuroscience 1995, 65, 119–160. [Google Scholar] [CrossRef]
  118. Abrams, P.; Andersson, K.E.; Buccafusco, J.J.; Chapple, C.; de Groat, W.C.; Fryer, A.D.; Kay, G.; Laties, A.; Nathanson, N.M.; Pasricha, P.J.; et al. Muscarinic receptors: Their distribution and function in body systems, and the implications for treating overactive bladder. Br. J. Pharm. 2006, 148, 565–578. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  119. Breton-Provencher, V.; Sur, M. Active control of arousal by a locus coeruleus GABAergic circuit. Nat. Neurosci. 2019, 22, 218–228. [Google Scholar] [CrossRef] [PubMed]
  120. Lewis, D.A.; Morrison, J.H. Noradrenergic innervation of monkey prefrontal cortex: A dopamine-beta-hydroxylase immunohistochemical study. J. Comp. Neurol. 1989, 282, 317–330. [Google Scholar] [CrossRef] [PubMed]
  121. Morrison, J.H.; Foote, S.L. Noradrenergic and serotoninergic innervation of cortical, thalamic, and tectal visual structures in Old and New World monkeys. J. Comp. Neurol. 1986, 243, 117–138. [Google Scholar] [CrossRef] [PubMed]
  122. Kebschull, J.M.; Garcia da Silva, P.; Reid, A.P.; Peikon, I.D.; Albeanu, D.F.; Zador, A.M. High-Throughput Mapping of Single-Neuron Projections by Sequencing of Barcoded RNA. Neuron 2016, 91, 975–987. [Google Scholar] [CrossRef]
  123. Hirschberg, S.; Li, Y.; Randall, A.; Kremer, E.J.; Pickering, A.E. Functional dichotomy in spinal- vs prefrontal-projecting locus coeruleus modules splits descending noradrenergic analgesia from ascending aversion and anxiety in rats. eLife 2017, 6, e29808. [Google Scholar] [CrossRef]
  124. Chandler, D.J.; Gao, W.J.; Waterhouse, B.D. Heterogeneous organization of the locus coeruleus projections to prefrontal and motor cortices. Proc. Natl. Acad. Sci. USA 2014, 111, 6816–6821. [Google Scholar] [CrossRef] [Green Version]
  125. Zerbi, V.; Floriou-Servou, A.; Markicevic, M.; Vermeiren, Y.; Sturman, O.; Privitera, M.; von Ziegler, L.; Ferrari, K.D.; Weber, B.; De Deyn, P.P.; et al. Rapid Reconfiguration of the Functional Connectome after Chemogenetic Locus Coeruleus Activation. Neuron 2019, 103, 702–718.e705. [Google Scholar] [CrossRef]
  126. Liu, Y.; Rodenkirch, C.; Moskowitz, N.; Schriver, B.; Wang, Q. Dynamic Lateralization of Pupil Dilation Evoked by Locus Coeruleus Activation Results from Sympathetic, Not Parasympathetic, Contributions. Cell Rep. 2017, 20, 3099–3112. [Google Scholar] [CrossRef]
  127. Robertson, S.D.; Plummer, N.W.; de Marchena, J.; Jensen, P. Developmental origins of central norepinephrine neuron diversity. Nat. Neurosci. 2013, 16, 1016–1023. [Google Scholar] [CrossRef] [Green Version]
  128. Jones, B.E. Noradrenergic locus coeruleus neurons: Their distant connections and their relationship to neighboring (including cholinergic and GABAergic) neurons of the central gray and reticular formation. In Progress in Brain Research; Barnes, C.D., Pompeiano, O., Eds.; Elsevier: Amsterdam, The Netherlands, 1991; Volume 88, pp. 15–30. [Google Scholar]
  129. Williams, J.A.; Reiner, P.B. Noradrenaline hyperpolarizes identified rat mesopontine cholinergic neurons in vitro. J. Neurosci. 1993, 13, 3878–3883. [Google Scholar] [CrossRef] [PubMed]
  130. Pisani, A.; Bonsi, P.; Centonze, D.; Martorana, A.; Fusco, F.; Sancesario, G.; De Persis, C.; Bernardi, G.; Calabresi, P. Activation of β1-Adrenoceptors Excites Striatal Cholinergic Interneurons through a cAMP-Dependent, Protein Kinase-Independent Pathway. J. Neurosci. 2003, 23, 5272–5282. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  131. Manns, I.D.; Lee, M.G.; Modirrousta, M.; Hou, Y.P.; Jones, B.E. Alpha 2 adrenergic receptors on GABAergic, putative sleep-promoting basal forebrain neurons. Eur. J. Neurosci. 2003, 18, 723–727. [Google Scholar] [CrossRef]
  132. Szabadi, E. Functional neuroanatomy of the central noradrenergic system. J. Psychopharmacol. 2013, 27, 659–693. [Google Scholar] [CrossRef]
  133. Carter, M.E.; Yizhar, O.; Chikahisa, S.; Nguyen, H.; Adamantidis, A.; Nishino, S.; Deisseroth, K.; de Lecea, L. Tuning arousal with optogenetic modulation of locus coeruleus neurons. Nat. Neurosci. 2010, 13, 1526–1533. [Google Scholar] [CrossRef]
  134. Xu, M.; Chung, S.; Zhang, S.; Zhong, P.; Ma, C.; Chang, W.-C.; Weissbourd, B.; Sakai, N.; Luo, L.; Nishino, S.; et al. Basal forebrain circuit for sleep-wake control. Nat. Neurosci. 2015, 18, 1641–1647. [Google Scholar] [CrossRef]
  135. Rho, H.-J.; Kim, J.-H.; Lee, S.-H. Function of Selective Neuromodulatory Projections in the Mammalian Cerebral Cortex: Comparison Between Cholinergic and Noradrenergic Systems. Front. Neural. Circuits 2018, 12, 47. [Google Scholar] [CrossRef]
  136. Lena, C.; de Kerchove D’Exaerde, A.; Cordero-Erausquin, M.; Le Novere, N.; del Mar Arroyo-Jimenez, M.; Changeux, J.P. Diversity and distribution of nicotinic acetylcholine receptors in the locus ceruleus neurons. Proc. Natl. Acad. Sci. USA 1999, 96, 12126–12131. [Google Scholar] [CrossRef] [Green Version]
  137. Woo, R.S.; Park, E.Y.; Shin, M.S.; Jeong, M.S.; Zhao, R.J.; Shin, B.S.; Kim, C.J.; Park, J.W.; Kim, K.W. Mechanism of nicotine-evoked release of 3H-noradrenaline in human cerebral cortex slices. Br J. Pharm. 2002, 137, 1063–1070. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  138. El-Etri, M.M.; Ennis, M.; Griff, E.R.; Shipley, M.T. Evidence for cholinergic regulation of basal norepinephrine release in the rat olfactory bulb. Neuroscience 1999, 93, 611–617. [Google Scholar] [CrossRef]
  139. Lomax, P.; Foster, R.S.; Kirkpatrick, W.E. Cholinergic and adrenergic interactions in the thermoregulatory centers of the rat. Brain Res. 1969, 15, 431–438. [Google Scholar] [CrossRef]
  140. Brown, V.J.; Bowman, E.M. Rodent models of prefrontal cortical function. Trends Neurosci. 2002, 25, 340–343. [Google Scholar] [CrossRef]
  141. Dalley, J.W.; Cardinal, R.N.; Robbins, T.W. Prefrontal executive and cognitive functions in rodents: Neural and neurochemical substrates. Neurosci. Biobehav. Rev. 2004, 28, 771–784. [Google Scholar] [CrossRef] [PubMed]
  142. Furuyashiki, T.; Gallagher, M. Neural encoding in the orbitofrontal cortex related to goal-directed behavior. Ann. N. Y. Acad. Sci. 2007, 1121, 193–215. [Google Scholar] [CrossRef]
  143. Robbins, T.W. Chemical neuromodulation of frontal-executive functions in humans and other animals. Exp. Brain Res. 2000, 133, 130–138. [Google Scholar] [CrossRef]
  144. Chandler, D.J.; Lamperski, C.S.; Waterhouse, B.D. Identification and distribution of projections from monoaminergic and cholinergic nuclei to functionally differentiated subregions of prefrontal cortex. Brain Res. 2013, 1522, 38–58. [Google Scholar] [CrossRef] [Green Version]
  145. Eisenach, J.C.; Detweiler, D.J.; Tong, C.; D’Angelo, R.; Hood, D.D. Cerebrospinal Fluid Norepinephrine and Acetylcholine Concentrations During Acute Pain. Anesth. Analg. 1996, 82, 621–626. [Google Scholar] [CrossRef]
  146. Decker, M.W.; McGaugh, J.L. The role of interactions between the cholinergic system and other neuromodulatory systems in learing and memory. Synapse 1991, 7, 151–168. [Google Scholar] [CrossRef]
  147. Mason, S.T.; Fibiger, H.C. Interaction between noradrenergic and cholinergic systems in the rat brain: Behavioural function in locomotor activity. Neuroscience 1979, 4, 517–525. [Google Scholar] [CrossRef]
  148. Beane, M.; Marrocco, R.T. Norepinephrine and acetylcholine mediation of the components of reflexive attention: Implications for attention deficit disorders. Prog. Neurobiol. 2004, 74, 167–181. [Google Scholar] [CrossRef]
  149. Wotton, C.A.; Cross, C.D.; Bekar, L.K. Serotonin, norepinephrine, and acetylcholine differentially affect astrocytic potassium clearance to modulate somatosensory signaling in male mice. J. Neurosci. Res. 2020, 98, 964–977. [Google Scholar] [CrossRef] [PubMed]
  150. Barik, J.; Wonnacott, S. Indirect Modulation by α7 Nicotinic Acetylcholine Receptors of Noradrenaline Release in Rat Hippocampal Slices: Interaction with Glutamate and GABA Systems and Effect of Nicotine Withdrawal. Mol. Pharmacol. 2006, 69, 618–628. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  151. Summers, K.L.; Giacobini, E. Effects of local and repeated systemic administration of (−)nicotine on extracellular levels of acetylcholine, norepinephrine, dopamine, and serotonin in rat cortex. Neurochem. Res. 1995, 20, 753–759. [Google Scholar] [CrossRef] [PubMed]
  152. Dani, J.A. Overview of nicotinic receptors and their roles in the central nervous system. Biol. Psychiatry 2001, 49, 166–174. [Google Scholar] [CrossRef]
  153. Colquhoun, L.M.; Patrick, J.W. Pharmacology of neuronal nicotinic acetylcholine receptor subtypes. Adv Pharm. 1997, 39, 191–220. [Google Scholar] [CrossRef]
  154. Le Novere, N.; Changeux, J.P. Molecular evolution of the nicotinic acetylcholine receptor: An example of multigene family in excitable cells. J. Mol. Evol. 1995, 40, 155–172. [Google Scholar] [CrossRef]
  155. McGehee, D.S.; Role, L.W. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu. Rev. Physiol. 1995, 57, 521–546. [Google Scholar] [CrossRef]
  156. Charpantier, E.; Barneoud, P.; Moser, P.; Besnard, F.; Sgard, F. Nicotinic acetylcholine subunit mRNA expression in dopaminergic neurons of the rat substantia nigra and ventral tegmental area. Neuroreport 1998, 9, 3097–3101. [Google Scholar] [CrossRef]
  157. Tribollet, E.; Bertrand, D.; Marguerat, A.; Raggenbass, M. Comparative distribution of nicotinic receptor subtypes during development, adulthood and aging: An autoradiographic study in the rat brain. Neuroscience 2004, 124, 405–420. [Google Scholar] [CrossRef]
  158. Alkondon, M.; Pereira, E.F.; Eisenberg, H.M.; Albuquerque, E.X. Nicotinic receptor activation in human cerebral cortical interneurons: A mechanism for inhibition and disinhibition of neuronal networks. J. Neurosci. 2000, 20, 66–75. [Google Scholar] [CrossRef] [Green Version]
  159. Frazier, C.J.; Buhler, A.V.; Weiner, J.L.; Dunwiddie, T.V. Synaptic potentials mediated via alpha-bungarotoxin-sensitive nicotinic acetylcholine receptors in rat hippocampal interneurons. J. Neurosci. 1998, 18, 8228–8235. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  160. Porter, J.T.; Cauli, B.; Tsuzuki, K.; Lambolez, B.; Rossier, J.; Audinat, E. Selective excitation of subtypes of neocortical interneurons by nicotinic receptors. J. Neurosci. 1999, 19, 5228–5235. [Google Scholar] [CrossRef]
  161. Levy, R.B.; Aoki, C. Alpha7 nicotinic acetylcholine receptors occur at postsynaptic densities of AMPA receptor-positive and -negative excitatory synapses in rat sensory cortex. J. Neurosci. 2002, 22, 5001–5015. [Google Scholar] [CrossRef] [PubMed]
  162. Sihver, W.; Gillberg, P.G.; Nordberg, A. Laminar distribution of nicotinic receptor subtypes in human cerebral cortex as determined by [3H](-)nicotine, [3H]cytisine and [3H]epibatidine in vitro autoradiography. Neuroscience 1998, 85, 1121–1133. [Google Scholar] [CrossRef]
  163. Albuquerque, E.X.; Alkondon, M.; Pereira, E.F.; Castro, N.G.; Schrattenholz, A.; Barbosa, C.T.; Bonfante-Cabarcas, R.; Aracava, Y.; Eisenberg, H.M.; Maelicke, A. Properties of neuronal nicotinic acetylcholine receptors: Pharmacological characterization and modulation of synaptic function. J. Pharm. Exp. 1997, 280, 1117–1136. [Google Scholar]
  164. Smythies, J. The Neuromodulators; Academic Press: Cambridge, MA, USA, 2005. [Google Scholar]
  165. Adem, A.; Jolkkonen, M.; Bogdanovic, N.; Islam, A.; Karlsson, E. Localization of M1 muscarinic receptors in rat brain using selective muscarinic toxin-1. Brain Res. Bull 1997, 44, 597–601. [Google Scholar] [CrossRef]
  166. Mrzljak, L.; Levey, A.I.; Belcher, S.; Goldman-Rakic, P.S. Localization of the m2 muscarinic acetylcholine receptor protein and mRNA in cortical neurons of the normal and cholinergically deafferented rhesus monkey. J. Comp. Neurol. 1998, 390, 112–132. [Google Scholar] [CrossRef]
  167. Wei, J.; Walton, E.A.; Milici, A.; Buccafusco, J.J. m1–m5 muscarinic receptor distribution in rat CNS by RT-PCR and HPLC. J. Neurochem. 1994, 63, 815–821. [Google Scholar] [CrossRef]
  168. Marino, M.J.; Rouse, S.T.; Levey, A.I.; Potter, L.T.; Conn, P.J. Activation of the genetically defined m1 muscarinic receptor potentiates N-methyl-D-aspartate (NMDA) receptor currents in hippocampal pyramidal cells. Proc. Natl. Acad. Sci. USA 1998, 95, 11465–11470. [Google Scholar] [CrossRef] [Green Version]
  169. Fisahn, A.; Yamada, M.; Duttaroy, A.; Gan, J.W.; Deng, C.X.; McBain, C.J.; Wess, J. Muscarinic induction of hippocampal gamma oscillations requires coupling of the M1 receptor to two mixed cation currents. Neuron 2002, 33, 615–624. [Google Scholar] [CrossRef] [Green Version]
  170. Hamilton, S.E.; Nathanson, N.M. The M1 receptor is required for muscarinic activation of mitogen-activated protein (MAP) kinase in murine cerebral cortical neurons. J. Biol. Chem. 2001, 276, 15850–15853. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  171. Berkeley, J.L.; Gomeza, J.; Wess, J.; Hamilton, S.E.; Nathanson, N.M.; Levey, A.I. M1 muscarinic acetylcholine receptors activate extracellular signal-regulated kinase in CA1 pyramidal neurons in mouse hippocampal slices. Mol. Cell Neurosci. 2001, 18, 512–524. [Google Scholar] [CrossRef] [PubMed]
  172. Berkeley, J.L.; Levey, A.I. Muscarinic activation of mitogen-activated protein kinase in PC12 cells. J. Neurochem. 2000, 75, 487–493. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  173. Naude, J.; Dongelmans, M.; Faure, P. Nicotinic alteration of decision-making. Neuropharmacology 2015, 96, 244–254. [Google Scholar] [CrossRef] [PubMed]
  174. Kolokotroni, K.Z.; Rodgers, R.J.; Harrison, A.A. Acute nicotine increases both impulsive choice and behavioural disinhibition in rats. Psychopharmacology 2011, 217, 455–473. [Google Scholar] [CrossRef] [PubMed]
  175. Pittaras, E.C.; Faure, A.; Leray, X.; Moraitopoulou, E.; Cressant, A.; Rabat, A.A.; Meunier, C.; Fossier, P.; Granon, S. Neuronal Nicotinic Receptors Are Crucial for Tuning of E/I Balance in Prelimbic Cortex and for Decision-Making Processes. Front. Psychiatry 2016, 7, 171. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  176. Thomsen, M.S.; Hansen, H.H.; Timmerman, D.B.; Mikkelsen, J.D. Cognitive improvement by activation of alpha7 nicotinic acetylcholine receptors: From animal models to human pathophysiology. Curr. Pharm. Des. 2010, 16, 323–343. [Google Scholar] [CrossRef]
  177. Mendez, I.A.; Gilbert, R.J.; Bizon, J.L.; Setlow, B. Effects of acute administration of nicotinic and muscarinic cholinergic agonists and antagonists on performance in different cost-benefit decision making tasks in rats. Psychopharmacology 2012, 224, 489–499. [Google Scholar] [CrossRef] [Green Version]
  178. Goldberg, J.A.; Ding, J.B.; Surmeier, D.J. Muscarinic modulation of striatal function and circuitry. Handb. Exp. Pharm. 2012, 223–241. [Google Scholar] [CrossRef]
  179. Silveira, M.M.; Malcolm, E.; Shoaib, M.; Winstanley, C.A. Scopolamine and amphetamine produce similar decision-making deficits on a rat gambling task via independent pathways. Behav. Brain Res. 2015, 281, 86–95. [Google Scholar] [CrossRef]
  180. Howe, W.M.; Gritton, H.J.; Lusk, N.A.; Roberts, E.A.; Hetrick, V.L.; Berke, J.D.; Sarter, M. Acetylcholine Release in Prefrontal Cortex Promotes Gamma Oscillations and Theta-Gamma Coupling during Cue Detection. J. Neurosci. 2017, 37, 3215–3230. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  181. Tort, A.B.; Komorowski, R.W.; Manns, J.R.; Kopell, N.J.; Eichenbaum, H. Theta-gamma coupling increases during the learning of item-context associations. Proc. Natl. Acad. Sci. USA 2009, 106, 20942–20947. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  182. Ridley, R.M.; Baker, H.F.; Drewett, B.; Johnson, J.A. Effects of ibotenic acid lesions of the basal forebrain on serial reversal learning in marmosets. Psychopharmacology 1985, 86, 438–443. [Google Scholar] [CrossRef] [PubMed]
  183. Groman, S.M. The Neurobiology of Impulsive Decision-Making and Reinforcement Learning in Nonhuman Animals. Curr. Top Behav. Neurosci. 2020, 47, 23–52. [Google Scholar] [CrossRef]
  184. Hasselmo, M.E.; Bower, J.M. Acetylcholine and memory. Trends Neurosci. 1993, 16, 218–222. [Google Scholar] [CrossRef]
  185. Doya, K. Metalearning and neuromodulation. Neural. Netw. 2002, 15, 495–506. [Google Scholar] [CrossRef]
  186. Gold, P.E. Acetylcholine modulation of neural systems involved in learning and memory. NeuroBiol. Learn Mem. 2003, 80, 194–210. [Google Scholar] [CrossRef]
  187. Passetti, F.; Dalley, J.W.; O’Connell, M.T.; Everitt, B.J.; Robbins, T.W. Increased acetylcholine release in the rat medial prefrontal cortex during performance of a visual attentional task. Eur. J. Neurosci. 2000, 12, 3051–3058. [Google Scholar] [CrossRef]
  188. Mirza, N.R.; Stolerman, I.P. The role of nicotinic and muscarinic acetylcholine receptors in attention. Psychopharmacology 2000, 148, 243–250. [Google Scholar] [CrossRef]
  189. Robbins, T.W. The 5-choice serial reaction time task: Behavioural pharmacology and functional neurochemistry. Psychopharmacology 2002, 163, 362–380. [Google Scholar] [CrossRef]
  190. Howe, W.M.; Ji, J.; Parikh, V.; Williams, S.; Mocaer, E.; Trocme-Thibierge, C.; Sarter, M. Enhancement of attentional performance by selective stimulation of alpha4beta2(*) nAChRs: Underlying cholinergic mechanisms. Neuropsychopharmacology 2010, 35, 1391–1401. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  191. Guillem, K.; Bloem, B.; Poorthuis, R.B.; Loos, M.; Smit, A.B.; Maskos, U.; Spijker, S.; Mansvelder, H.D. Nicotinic acetylcholine receptor beta2 subunits in the medial prefrontal cortex control attention. Science 2011, 333, 888–891. [Google Scholar] [CrossRef] [PubMed]
  192. Furey, M.L.; Pietrini, P.; Haxby, J.V.; Drevets, W.C. Selective effects of cholinergic modulation on task performance during selective attention. Neuropsychopharmacology 2008, 33, 913–923. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  193. Erskine, F.F.; Ellis, J.R.; Ellis, K.A.; Stuber, E.; Hogan, K.; Miller, V.; Moore, E.; Bartholomeusz, C.; Harrison, B.J.; Lee, B.; et al. Evidence for synergistic modulation of early information processing by nicotinic and muscarinic receptors in humans. Hum. Psychopharmacol. 2004, 19, 503–509. [Google Scholar] [CrossRef] [PubMed]
  194. Mentis, M.J.; Sunderland, T.; Lai, J.; Connolly, C.; Krasuski, J.; Levine, B.; Friz, J.; Sobti, S.; Schapiro, M.; Rapoport, S.I. Muscarinic versus nicotinic modulation of a visual task. a pet study using drug probes. Neuropsychopharmacology 2001, 25, 555–564. [Google Scholar] [CrossRef] [Green Version]
  195. Herrero, J.L.; Roberts, M.J.; Delicato, L.S.; Gieselmann, M.A.; Dayan, P.; Thiele, A. Acetylcholine contributes through muscarinic receptors to attentional modulation in V1. Nature 2008, 454, 1110–1114. [Google Scholar] [CrossRef]
  196. Zink, N.; Bensmann, W.; Arning, L.; Stock, A.K.; Beste, C. CHRM2 Genotype Affects Inhibitory Control Mechanisms During Cognitive Flexibility. Mol. Neurobiol. 2019, 56, 6134–6141. [Google Scholar] [CrossRef]
  197. Ahlquist, R.P. A study of the adrenotropic receptors. Am. J. Physiol. 1948, 153, 586–600. [Google Scholar] [CrossRef]
  198. Blendy, J.A.; Grimm, L.J.; Perry, D.C.; West-Johnsrud, L.; Kellar, K.J. Electroconvulsive shock differentially increases binding to alpha-1 adrenergic receptor subtypes in discrete regions of rat brain. J. Neurosci. 1990, 10, 2580–2586. [Google Scholar] [CrossRef]
  199. Papay, R.; Gaivin, R.; Jha, A.; McCune, D.F.; McGrath, J.C.; Rodrigo, M.C.; Simpson, P.C.; Doze, V.A.; Perez, D.M. Localization of the mouse alpha1A-adrenergic receptor (AR) in the brain: alpha1AAR is expressed in neurons, GABAergic interneurons, and NG2 oligodendrocyte progenitors. J. Comp. Neurol. 2006, 497, 209–222. [Google Scholar] [CrossRef]
  200. Tanoue, A.; Nasa, Y.; Koshimizu, T.; Shinoura, H.; Oshikawa, S.; Kawai, T.; Sunada, S.; Takeo, S.; Tsujimoto, G. The α1D-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction. J. Clin. Investig. 2002, 109, 765–775. [Google Scholar] [CrossRef]
  201. Cavalli, A.; Lattion, A.-L.; Hummler, E.; Nenniger, M.; Pedrazzini, T.; Aubert, J.-F.; Michel, M.C.; Yang, M.; Lembo, G.; Vecchione, C.; et al. Decreased blood pressure response in mice deficient of the α1b-adrenergic receptor. Proc. Natl. Acad. Sci. USA 1997, 94, 11589–11594. [Google Scholar] [CrossRef] [Green Version]
  202. Rokosh, D.G.; Simpson, P.C. Knockout of the α1A/C-adrenergic receptor subtype: The α1A/C is expressed in resistance arteries and is required to maintain arterial blood pressure. Proc. Natl. Acad. Sci. USA 2002, 99, 9474–9479. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  203. Kobayashi, M.; Kojima, M.; Koyanagi, Y.; Adachi, K.; Imamura, K.; Koshikawa, N. Presynaptic and postsynaptic modulation of glutamatergic synaptic transmission by activation of α1- and β-adrenoceptors in layer V pyramidal neurons of rat cerebral cortex. Synapse 2009, 63, 269–281. [Google Scholar] [CrossRef] [PubMed]
  204. Mouradian, R.D.; Sessler, F.M.; Waterhouse, B.D. Noradrenergic potentiation of excitatory transmitter action in cerebrocortical slices: Evidence for mediation by an α1 receptor-linked second messenger pathway. Brain Res. 1991, 546, 83–95. [Google Scholar] [CrossRef]
  205. Gordon, G.R.J.; Bains, J.S. Priming of Excitatory Synapses by α1 Adrenoceptor-Mediated Inhibition of Group III Metabotropic Glutamate Receptors. J. Neurosci. 2003, 23, 6223–6231. [Google Scholar] [CrossRef] [Green Version]
  206. Luo, F.; Tang, H.; Li, B.-m.; Li, S.-h. Activation of α1-adrenoceptors enhances excitatory synaptic transmission via a pre- and postsynaptic protein kinase C-dependent mechanism in the medial prefrontal cortex of rats. Eur. J. Neurosci. 2014, 39, 1281–1293. [Google Scholar] [CrossRef]
  207. Velásquez-Martinez, M.C.; Vázquez-Torres, R.; Jiménez-Rivera, C.A. Activation of alpha1-adrenoceptors enhances glutamate release onto ventral tegmental area dopamine cells. Neuroscience 2012, 216, 18–30. [Google Scholar] [CrossRef] [Green Version]
  208. Chen, Q.; Li, D.-P.; Pan, H.-L. Presynaptic α1 Adrenergic Receptors Differentially Regulate Synaptic Glutamate and GABA Release to Hypothalamic Presympathetic Neurons. J. Pharmacol. Exp. Ther. 2006, 316, 733–742. [Google Scholar] [CrossRef]
  209. Marek, G.J.; Aghajanian, G.K. 5-HT2A receptor or α1-adrenoceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex. Eur. J. Pharmacol. 1999, 367, 197–206. [Google Scholar] [CrossRef]
  210. Shao, Y.; Sutin, J. Expression of adrenergic receptors in individual astrocytes and motor neurons isolated from the adult rat brain. Glia 1992, 6, 108–117. [Google Scholar] [CrossRef]
  211. Bekar, L.K.; He, W.; Nedergaard, M. Locus Coeruleus α-Adrenergic–Mediated Activation of Cortical Astrocytes In Vivo. Cereb. Cortex 2008, 18, 2789–2795. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  212. Kulik, A.; Haentzsch, A.; Lückermann, M.; Reichelt, W.; Ballanyi, K. Neuron–Glia Signaling via α1 Adrenoceptor-Mediated Ca2+ Release in Bergmann Glial Cells In Situ. J. Neurosci. 1999, 19, 8401–8408. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  213. Perez, D.M. alpha1-Adrenergic Receptors in Neurotransmission, Synaptic Plasticity, and Cognition. Front. Pharm. 2020, 11, 581098. [Google Scholar] [CrossRef]
  214. Trendelenburg, A.U.; Limberger, N.; Rump, L.C. Alpha 2-adrenergic receptors of the alpha 2c subtype mediate inhibition of norepinephrine release in human kidney cortex. Mol. Pharmacol. 1994, 45, 1168–1176. [Google Scholar] [PubMed]
  215. Giovannitti, J.A., Jr.; Thoms, S.M.; Crawford, J.J. Alpha-2 adrenergic receptor agonists: A review of current clinical applications. Anesth. Prog. 2015, 62, 31–39. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  216. Bylund, D.B. Alpha-2 Adrenoceptors. In xPharm: The Comprehensive Pharmacology Reference; Enna, S.J., Bylund, D.B., Eds.; Elsevier: New York, NY, USA, 2007; pp. 1–9. [Google Scholar]
  217. Philipp, M.; Brede, M.; Hein, L. Physiological significance of alpha(2)-adrenergic receptor subtype diversity: One receptor is not enough. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002, 283, R287–R295. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  218. Hagena, H.; Hansen, N.; Manahan-Vaughan, D. β-Adrenergic Control of Hippocampal Function: Subserving the Choreography of Synaptic Information Storage and Memory. Cereb. Cortex 2016, 26, 1349–1364. [Google Scholar] [CrossRef] [Green Version]
  219. Dayan, P.; Yu, A.J. Phasic norepinephrine: A neural interrupt signal for unexpected events. Network 2006, 17, 335–350. [Google Scholar] [CrossRef] [Green Version]
  220. Ego-Stengel, V.; Bringuier, V.; Shulz, D.E. Noradrenergic modulation of functional selectivity in the cat visual cortex: An in vivo extracellular and intracellular study. Neuroscience 2002, 111, 275–289. [Google Scholar] [CrossRef]
  221. Bouret, S.; Sara, S.J. Network reset: A simplified overarching theory of locus coeruleus noradrenaline function. Trends Neurosci. 2005, 28, 574–582. [Google Scholar] [CrossRef] [PubMed]
  222. Joshi, S.; Gold, J.I. Context-dependent relationships between locus coeruleus firing patterns and coordinated neural activity in the anterior cingulate cortex. eLife 2022, 11, e63490. [Google Scholar] [CrossRef] [PubMed]
  223. Gu, Q. Neuromodulatory transmitter systems in the cortex and their role in cortical plasticity. Neuroscience 2002, 111, 815–835. [Google Scholar] [CrossRef]
  224. Montes, D.R.; Stopper, C.M.; Floresco, S.B. Noradrenergic modulation of risk/reward decision making. Psychopharmacology 2015, 232, 2681–2696. [Google Scholar] [CrossRef]
  225. Kim, S.; Bobeica, I.; Gamo, N.J.; Arnsten, A.F.; Lee, D. Effects of alpha-2A adrenergic receptor agonist on time and risk preference in primates. Psychopharmacology 2012, 219, 363–375. [Google Scholar] [CrossRef] [Green Version]
  226. Steere, J.C.; Arnsten, A.F. The alpha-2A noradrenergic receptor agonist guanfacine improves visual object discrimination reversal performance in aged rhesus monkeys. Behav. Neurosci. 1997, 111, 883–891. [Google Scholar] [CrossRef]
  227. Aston-Jones, G.; Chiang, C.; Alexinsky, T. Discharge of noradrenergic locus coeruleus neurons in behaving rats and monkeys suggests a role in vigilance. Prog. Brain Res. 1991, 88, 501–520. [Google Scholar]
  228. Foote, S.L.; Berridge, C.W.; Adams, L.M.; Pineda, J.A. Electrophysiological evidence for the involvement of the locus coeruleus in alerting, orienting, and attending. Prog. Brain Res. 1991, 88, 521–532. [Google Scholar] [CrossRef]
  229. Aston-Jones, G.; Bloom, F.E. Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J. Neurosci. 1981, 1, 876–886. [Google Scholar] [CrossRef]
  230. Livingstone, M.S.; Hubel, D.H. Effects of sleep and arousal on the processing of visual information in the cat. Nature 1981, 291, 554–561. [Google Scholar] [CrossRef]
  231. McCormick, D.A.; Pape, H.C.; Williamson, A. Actions of norepinephrine in the cerebral cortex and thalamus: Implications for function of the central noradrenergic system. In Progress in Brain Research; Barnes, C.D., Pompeiano, O., Eds.; Elsevier: Amsterdam, The Netherlands, 1991; Volume 88, pp. 293–305. [Google Scholar]
  232. Mountcastle, V.B.; Andersen, R.A.; Motter, B.C. The influence of attentive fixation upon the excitability of the light- sensitive neurons of the posterior parietal cortex. J. Neurosci. 1981, 1, 1218. [Google Scholar] [CrossRef] [Green Version]
  233. Hyvarinen, J.; Poranen, A.; Jokinen, Y. Influence of attentive behavior on neuronal responses to vibration in primary somatosensory cortex of the monkey. J. Neurophysiol. 1980, 43, 870–882. [Google Scholar] [CrossRef]
  234. Coull, J.T.; Nobre, A.C.; Frith, C.D. The Noradrenergic α2 Agonist Clonidine Modulates Behavioural and Neuroanatomical Correlates of Human Attentional Orienting and Alerting. Cereb. Cortex 2001, 11, 73–84. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  235. Spencer, T.; Biederman, J.; Heiligenstein, J.; Wilens, T.; Faries, D.; Prince, J.; Faraone, S.V.; Rea, J.; Witcher, J.; Zervas, S. An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder. J. Child Adolesc. Psychopharmacol. 2001, 11, 251–265. [Google Scholar] [CrossRef] [PubMed]
  236. Sigurdardottir, H.L.; Kranz, G.S.; Rami-Mark, C.; James, G.M.; Vanicek, T.; Gryglewski, G.; Berroterán-Infante, N.; Kautzky, A.; Hienert, M.; Traub-Weidinger, T.; et al. Association of norepinephrine transporter methylation with in vivo NET expression and hyperactivity-impulsivity symptoms in ADHD measured with PET. Mol. Psychiatry 2021, 26, 1009–1018. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  237. Dippel, G.; Mückschel, M.; Ziemssen, T.; Beste, C. Demands on response inhibition processes determine modulations of theta band activity in superior frontal areas and correlations with pupillometry—Implications for the norepinephrine system during inhibitory control. NeuroImage 2017, 157, 575–585. [Google Scholar] [CrossRef]
  238. Eggermann, E.; Kremer, Y.; Crochet, S.; Petersen, C.C.H. Cholinergic Signals in Mouse Barrel Cortex during Active Whisker Sensing. Cell Rep. 2014, 9, 1654–1660. [Google Scholar] [CrossRef] [Green Version]
  239. Aston-Jones, G.; Cohen, J.D. An integrative theory of locus coeruleus-norepinephrine function: Adaptive gain and optimal performance. Annu. Rev. Neurosci. 2005, 28, 403–450. [Google Scholar] [CrossRef] [Green Version]
  240. Steriade, M.; McCarley, R.W. Brain Control of Wakefulness and Sleep; Springer: Boston, MA, USA, 2005. [Google Scholar]
  241. Reimer, J.; McGinley, M.J.; Liu, Y.; Rodenkirch, C.; Wang, Q.; McCormick, D.A.; Tolias, A.S. Pupil fluctuations track rapid changes in adrenergic and cholinergic activity in cortex. Nat. Commun. 2016, 7, 13289. [Google Scholar] [CrossRef]
  242. Hirata, A.; Aguilar, J.; Castro-Alamancos, M.A. Noradrenergic activation amplifies bottom-up and top-down signal-to-noise ratios in sensory thalamus. J. Neurosci. 2006, 26, 4426–4436. [Google Scholar] [CrossRef]
  243. Koger, S.M.; Mair, R.G. Depletion of cortical norepinephrine in rats by 6-hydroxydopamine does not impair performance of a delayed-nonmatching-to-sample task. Behav. Neurosci. 1992, 106, 718–721. [Google Scholar] [CrossRef] [PubMed]
  244. McGaughy, J.; Sandstrom, M.; Ruland, S.; Bruno, J.P.; Sarter, M. Lack of effects of lesions of the dorsal noradrenergic bundle on behavioral vigilance. Behav. Neurosci. 1997, 111, 646–652. [Google Scholar] [CrossRef] [PubMed]
  245. Chandler, D.; Waterhouse, B.D. Evidence for broad versus segregated projections from cholinergic and noradrenergic nuclei to functionally and anatomically discrete subregions of prefrontal cortex. Front. Behav. Neurosci. 2012, 6, 20. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  246. Dalley, J.W.; McGaughy, J.; Connell, M.T.; Cardinal, R.N.; Levita, L.; Robbins, T.W. Distinct Changes in Cortical Acetylcholine and Noradrenaline Efflux during Contingent and Noncontingent Performance of a Visual Attentional Task. J. Neurosci. 2001, 21, 4908. [Google Scholar] [CrossRef] [Green Version]
  247. McGaughy, J.; Ross, R.S.; Eichenbaum, H. Noradrenergic, but not cholinergic, deafferentation of prefrontal cortex impairs attentional set-shifting. Neuroscience 2008, 153, 63–71. [Google Scholar] [CrossRef] [Green Version]
  248. Disney, A.A. Neuromodulatory Control of Early Visual Processing in Macaque. Annu. Rev. Vis. Sci. 2021, 7, 181–199. [Google Scholar] [CrossRef]
  249. Doya, K. Modulators of decision making. Nat. Neurosci. 2008, 11, 410–416. [Google Scholar] [CrossRef]
  250. Sethuramanujam, S.; Matsumoto, A.; deRosenroll, G.; Murphy-Baum, B.; Grosman, C.; McIntosh, J.M.; Jing, M.; Li, Y.; Berson, D.; Yonehara, K.; et al. Rapid multi-directed cholinergic transmission in the central nervous system. Nat. Commun. 2021, 12, 1374. [Google Scholar] [CrossRef]
  251. Yu, A.J.; Dayan, P. Uncertainty, neuromodulation, and attention. Neuron 2005, 46, 681–692. [Google Scholar] [CrossRef] [Green Version]
  252. Deppe, M.; Schwindt, W.; Kugel, H.; Plaßmann, H.; Kenning, P. Nonlinear Responses Within the Medial Prefrontal Cortex Reveal When Specific Implicit Information Influences Economic Decision Making. J. Neuroimaging 2005, 15, 171–182. [Google Scholar] [CrossRef]
  253. Euston, D.R.; Gruber, A.J.; McNaughton, B.L. The Role of Medial Prefrontal Cortex in Memory and Decision Making. Neuron 2012, 76, 1057–1070. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  254. Orsini, C.A.; Heshmati, S.C.; Garman, T.S.; Wall, S.C.; Bizon, J.L.; Setlow, B. Contributions of medial prefrontal cortex to decision making involving risk of punishment. Neuropharmacology 2018, 139, 205–216. [Google Scholar] [CrossRef] [PubMed]
  255. Sul, J.H.; Kim, H.; Huh, N.; Lee, D.; Jung, M.W. Distinct Roles of Rodent Orbitofrontal and Medial Prefrontal Cortex in Decision Making. Neuron 2010, 66, 449–460. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  256. Rodenkirch, C.; Schriver, B.; Wang, Q. Brain-Machine Interfaces: Restoring and Establishing Communication Channels. In Neural Engineering: From Advanced Biomaterials to 3D Fabrication Techniques; Zhang, L., Kaplan, D., Eds.; Springer: Cham, Switzerland, 2016. [Google Scholar]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Slater, C.; Liu, Y.; Weiss, E.; Yu, K.; Wang, Q. The Neuromodulatory Role of the Noradrenergic and Cholinergic Systems and Their Interplay in Cognitive Functions: A Focused Review. Brain Sci. 2022, 12, 890. https://doi.org/10.3390/brainsci12070890

AMA Style

Slater C, Liu Y, Weiss E, Yu K, Wang Q. The Neuromodulatory Role of the Noradrenergic and Cholinergic Systems and Their Interplay in Cognitive Functions: A Focused Review. Brain Sciences. 2022; 12(7):890. https://doi.org/10.3390/brainsci12070890

Chicago/Turabian Style

Slater, Cody, Yuxiang Liu, Evan Weiss, Kunpeng Yu, and Qi Wang. 2022. "The Neuromodulatory Role of the Noradrenergic and Cholinergic Systems and Their Interplay in Cognitive Functions: A Focused Review" Brain Sciences 12, no. 7: 890. https://doi.org/10.3390/brainsci12070890

APA Style

Slater, C., Liu, Y., Weiss, E., Yu, K., & Wang, Q. (2022). The Neuromodulatory Role of the Noradrenergic and Cholinergic Systems and Their Interplay in Cognitive Functions: A Focused Review. Brain Sciences, 12(7), 890. https://doi.org/10.3390/brainsci12070890

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop